Plants with reduced lipase 1 activity

ABSTRACT

The disclosure relates to a series of independent human-induced non-transgenic mutations found at one or more of the Lip1 genes of a plant; plants having these mutations in one or more of their Lip1 genes; and a method of creating and finding similar and/or additional mutations of Lip1 by screening pooled and/or individual plants. The plants disclosed herein exhibit decreased lipase activity without having the inclusion of foreign nucleic acids in their genomes. Additionally, products produced from the plants disclosed herein exhibit increased hydrolytic and oxidative stability and increased shelf life without having the inclusion of foreign nucleic acids in their genomes.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 16/653,288, filed Oct. 15, 2019, which is a continuation of U.S. patent application Ser. No. 15/624,974, filed Jun. 16, 2017, which issued as U.S. Pat. No. 10,463,051 on Nov. 5, 2019, which claims priority to and is a non-provisional application of U.S. Provisional Patent Application Ser. No. 62/351,584 filed Jun. 17, 2016, all of which are incorporated herein by reference in their entirety.

FIELD

In one embodiment, the disclosure relates to a plant gene associated with shelf-life stability, rancidity and improved flavor of a plant product. In another embodiment, the disclosure relates to altering the expression or activity of one or more Lipase 1 (Lip1) genes in a plant. In one embodiment, the disclosure relates to human-induced non-transgenic mutations in one or more Lip1 genes of plants, including but not limited to wheat and rice.

SUBMISSION OF SEQUENCE LISTING

The contents of the electronic submission of the text file Sequence Listing, which is titled ARC-39563.txt, which was created Apr. 9, 2018, and is 89.0 KB in size, is incorporated herein by reference in its entirety.

BACKGROUND

Cereal crops are very important to a majority of the world's populations. For instance, wheat is the most important staple food of about two billion people (36% of the world population). Worldwide, wheat provides nearly 55% of the carbohydrates and 20% of the food calories consumed globally. It exceeds in acreage and production every other grain crop (including rice, maize, etc.) and is cultivated over a wide range of climatic conditions and the understanding of genetics and genome organization using molecular markers is of great value for genetic and plant breeding purposes.

The world's main wheat producing regions are China, India, United States, Russian Federation, France, Australia, Germany, Ukraine, Canada, Turkey, Pakistan, Argentina, Kazakhstan and United Kingdom. Most of the currently cultivated wheat varieties belong to Triticum aestivum L., which is known as common bread wheat and valued for bread making. The greatest portion of the wheat flour produced is used for bread making.

Bread wheat is a hexaploid, with three complete genomes termed A, B and D in the nucleus of each cell. Each of these genomes is almost twice the size of the human genome and consists of around 5,500 million nucleotides. On the other hand, durum wheat, also known as macaroni wheat or pasta wheat (Triticum durum or Triticum turgidum subsp. durum), is the major tetraploid species of wheat of commercial importance, which is widely cultivated today. Durum wheat has two complete genomes, termed the A and B genomes.

Wheat is a widely studied plant, but in some cases, development of new traits is hampered by limited genetic diversity in today's commercial wheat cultivars and also because the bread wheat genome typically has three functionally redundant copies of each gene (called homoeologs), and therefore, single gene alterations usually do not produce any readily visible phenotype such as those that have been found in diploid corn. Often in bread wheat, altered variants of all three homoeologs must be combined genetically in order to evaluate their effects.

Whole grain products present a challenge to the wheat industry because whole grain flour has a greatly reduced shelf life compared to refined flour (Doblado-Maldonado 2012). The reduced shelf life of whole grain flour is due primarily to degradation of lipids, which are the most unstable components of the milled whole grain (Pomeranz 1988; Tait and Gailliard 1998). Lipid degradation leads to the production of bitter, rancid and off flavors that negatively impact the shelf life and use of whole grain flour and products made from it. Similarly, stability and reduced shelf life are issues for the use of rice bran and products derived from it such as rice bran oil, due to the degradation of lipids.

The degradation of lipids occurs through the processes of both hydrolytic and oxidative rancidity. Lipases (EC 3.1.1.3) catalyze the hydrolysis of ester bonds in mono-, di- and tri-acylglycerides (TAG) into non-esterified or free fatty acids (FFA). Lipid degradation begins immediately upon milling whole grain flour or rice bran. Lipases have substantial enzymatic activity even at the low moisture content of milled grain (typically 10-14% for wheat) (Doblado-Maldonado 2012). Lipids can also be further degraded through autooxidation or by lipoxygenases (Lpx's). Lpx's (EC 1.13.11.12) are a class of non-heme iron-containing dioxygenases that catalyse the positional and specific dioxygenation of polyunsaturated fatty acids that contain 1,4-cis,cis pentadiene structures to produce the corresponding hydroperoxides. Following the formation of hydroperoxides, further degradation of lipids leads to the formation of smaller volatile compounds such as epoxyaldehydes, ketones, furans and lactones that cause off flavors and odors and reduce the shelf life of materials. Attempts to inactivate or reduce lipase and lipoxygenase activity in whole grain flour or rice bran by microwave, heat, vacuum, cold storage or chemical treatment have met with limited success or are very expensive to employ commercially.

Relatively few plant lipases have been characterized at the molecular and biochemical level (Seth et al. 2014 Protein Exp and Pur 95:13-21). For example, the rice genome annotation project currently has 73 genes annotated as putative lipases (Kawahara et al. (2013) Rice 6:4), but difficulties encountered in purification of rice lipase enzymes has hindered their characterization (Muniandy, K., et al. The Nucleus (2015): 1-6). Despite these difficulties, several rice bran lipolytic enzymes have been identified biochemically including Lipase I, Lipase II, a thermally stable lipase and an esterase (OsEST-b), (reviewed in Muniandy 2015 and Chuang et al. Journal of agricultural and food chemistry 59.5 (2011): 2019-2025). Of these enzymes, Lipase II and OsEST-b were recently purified and the rice genes coding for the enzymes have been identified (Vijayakumar and Protein expression and purification 88.1 (2013): 67-79; Chuang et al. 2011).

In wheat, lipase activities have been described in multiple tissues, including ungerminated wheat bran and wheat germ fractions as well as lipases produced during germination (Pomeranz, Y. Wheat: chemistry and technology. No. Ed. 3. American Association of Cereal Chemists, 1988). However, the genes coding for these lipases are largely uncharacterized. The present inventors have identified the Lipase 1 genes in wheat, in which the expression is located in the grain of the wheat plant.

The inventors have identified novel human induced non-transgenic Lip1 mutations and analyzed their phenotypes in plants, such as wheat and rice. With regard to wheat, since multiple Lipase genes (Lip 1, 2 and 3) are all expressed, each with one or more potential homoeologs in the A, B, and D genomes, it is unclear if altering one gene or gene family could positively affect shelf life or stability of whole grain flour in bread wheat. Mutations in the Lip1 genes in the wheat genome or rice genome provide a potential pathway for providing increased hydrolytic and oxidative stability in wheat/wheat flour and rice bran and products derived therefrom. The disclosure herein demonstrates that novel alleles in the Lip1 gene significantly improve shelf-life.

SUMMARY

In one embodiment, the disclosure relates to human-induced non-transgenic mutations in the Lip1 gene of plants. In one embodiment, the plant is a wheat plant or a rice plant.

In another embodiment, the disclosure relates to a plant, seeds, plant parts, and progeny thereof with decreased lipase activity compared to wild type plant, seeds, plant parts, and progeny thereof.

In another embodiment, the disclosure relates to a plant, seeds, plant parts, and progeny thereof with increased hydrolytic stability compared to wild type plant, seeds, plant parts, and progeny thereof.

In another embodiment, the disclosure relates to a plant, a seed, a plant part, and progeny thereof having reduced lipase activity compared to the wild type plant, wherein the reduction in lipase activity is caused by a human-induced non-transgenic mutation in one or more of the plant's Lip1 genes. In another embodiment, the Lip1 enzyme has reduced activity.

In another embodiment, the disclosure relates to a plant containing one or more mutated Lip1 genes, as well as seeds, pollen, plant parts and progeny of that plant.

In another embodiment, the disclosure relates to seeds, grain, milled grain, flour, or bran with increased hydrolytic stability from reduced Lip1 enzyme activity, which is caused by a human-induced non-transgenic mutation in one or more Lip1 genes

In another embodiment, the disclosure relates to seeds, grain, milled grain, flour or bran with increased oxidative stability from reduced Lip1 enzyme activity, which is caused by a human-induced non-transgenic mutation in one or more Lip1 genes

In another embodiment, the disclosure relates to seeds, grain, milled grain, flour or bran with improved sensory characteristics from reduced Lip1 enzyme activity, which is caused by a human-induced non-transgenic mutation in one or more Lip1 genes.

In one embodiment, the disclosure relates to plants having plant products, such as seeds and grains having a characteristic selected from the group consisting of increased shelf-life stability, reduced rancidity and improved flavor as a result of non-transgenic mutations in at least one of the Lip1 genes.

In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip1 gene of a plant including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In one embodiment, the disclosure relates to wheat plants having wheat seeds, wheat grain and wheat flour having a characteristic selected from the group consisting of increased shelf-life stability, reduced rancidity and improved flavor as a result of non-transgenic mutations in at least one of the Lip1 genes.

In one embodiment, the disclosure relates to human-induced non-transgenic mutations in the Lip1 genes in the A, B or D genomes of a wheat plant.

In one embodiment, the disclosure relates to non-transgenic mutations in one or more Lipase1 (Lip1) genes. In one embodiment, one or more mutations are in the Lip1 gene of the A genome of wheat. In another embodiment, one or more mutations are in the Lip1 gene of the D genome of wheat. In another embodiment, one or more mutations are in the Lip1 gene of the B genome of wheat.

In one embodiment, the disclosure relates to non-transgenic mutations in the Lip-A1 gene of the A genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In one embodiment, the disclosure relates to non-transgenic mutations in the Lip-D1 gene of the D genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In one embodiment, the disclosure relates to non-transgenic mutations in the Lip-B1 gene of the B genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In another embodiment, the disclosure relates to non-transgenic mutations in the Lip-A1 gene of the A genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and non-transgenic mutations in the Lip-D1 gene of the D genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In another embodiment, the disclosure relates to non-transgenic mutations in the Lip-A1 gene of the A genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and non-transgenic mutations in the Lip-B1 gene of the B genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In another embodiment, the disclosure relates to non-transgenic mutations in the Lip-A1 gene of the A genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and non-transgenic mutations in the Lip-B1 gene of the B genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations, and non-transgenic mutations in the Lip-D1 gene of the D genome of wheat including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In another embodiment, the disclosure relates to food, beverage, and food and beverage products incorporating a plant product, including but not limited to seeds, grain, milled grain, flour and bran having reduced Lip1 enzyme activity caused by a human-induced non-transgenic mutation in one or more Lip1 genes.

In another embodiment, this disclosure relates to a plant having reduced activity of one or more Lip1 enzymes compared to the wild type plants, created by the steps of obtaining plant material from a parent plant, inducing at least one mutation in at least one copy of an Lip1 gene of the plant material by treating the plant material with a mutagen to create mutagenized plant material (e.g., seeds or pollen), analyzing progeny plants to detect at least one mutation in at least one copy of a Lip1 gene, selecting progeny plants that have at least one mutation in at least one copy of an Lip1 gene, and optionally, crossing progeny plants that have at least one mutation in at least one copy of an Lip1 gene with other progeny plants that have at least one mutation in a different copy of an Lip1 gene, and repeating the cycle of identifying progeny plants having mutations and optionally crossing the progeny plants having mutations with other progeny plants having mutations to produce progeny plants with reduced Lip1 enzyme activity. In another embodiment, the method comprises growing or using the mutagenized plant material to produce progeny plants.

In another embodiment one or more mutations are in the Lip1 gene of a rice plant. In another embodiment, the disclosure relates to human-induced non-transgenic mutations in the Lip1 gene of rice and rice plants. In one embodiment, the disclosure relates to rice plants having rice seeds and bran with a characteristic selected from the group consisting of: increased shelf-life stability, increased oxidative stability, increased hydrolytic stability, reduced rancidity and improved flavor as a result of non-transgenic mutations in a Lip1 gene.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING

The nucleic acid sequences listed in the accompanying sequence listing are shown using standard letter abbreviations for nucleotide bases. Only one strand of each nucleic acid sequence is shown, but the complementary strand is understood to be included by any reference to the displayed strand. In the accompanying sequence listing:

SEQ ID NO: 1 shows a Triticum aestivum gene for Lipase 1, A genome, Lip-A1 exons 1-10 (3,280 base pairs).

SEQ ID NO: 2 shows the Lip-A1 coding sequence of SEQ ID NO: 1 (1,060 base pairs).

SEQ ID NO: 3 shows the Lip-A1 protein sequence of SEQ ID NO. 2 (352 amino acids).

SEQ ID NO: 4 shows a Triticum aestivum gene for Lipase 1, D genome, Lip-D1 exons 1-10 (3,263 base pairs).

SEQ ID NO: 5 shows the Lip-D1 coding sequence of SEQ ID NO. 4 (1,056 base pairs).

SEQ ID NO: 6 shows the Lip-D1 protein sequence of SEQ ID NO. 5 (351 amino acids).

SEQ ID NO: 7 shows a Triticum aestivum gene for Lipase 1, B genome, Lip-B1 exons 1-10 (3,460 base pairs).

SEQ ID NO: 8 shows the Lip-B1 coding sequence of SEQ ID NO. 4 (1,059 base pairs).

SEQ ID NO: 9 shows the Lip-B1 protein sequence of SEQ ID NO. 5 (352 amino acids).

SEQ ID NOs: 10-11 show exemplary homoeolog specific TILLING primers that have proven useful in identifying useful mutations within the Lip-A1 gene sequences.

SEQ ID NOs: 12-13 show exemplary homoeolog specific TILLING primers that have proven useful in identifying useful mutations within the Lip-D1 gene sequences.

SEQ ID NOs: 14-15 show exemplary homoeolog specific TILLING primers that have proven useful in identifying useful mutations within the Lip-B1 gene sequences.

SEQ ID NOs:16-17 show exemplary primers that have proven useful as markers for identifying intact or missing Lip-B1 locus sequences.

SEQ ID NOs: 18-19 show exemplary primers that have proven useful in expression analysis of the Lip1 genes in wheat.

SEQ ID NOs: 20-21 show exemplary primers that have proven useful in expression analysis of the Lip2 genes in wheat.

SEQ ID NOs: 22-23 show exemplary primers that have proven useful in expression analysis of the Lip3 genes in wheat.

SEQ ID NOs: 24-25 show exemplary primers that have proven useful in expression analysis of glyceraldehydephosphate dehydrogenase (GAPD).

SEQ ID NO: 26 shows an Oryza sativa gene for Lipase 1, OsLip1 exons 1-10 (3672 base pairs).

SEQ ID NO: 27 shows the OsLip1 coding region for SEQ ID NO: 26 (1,077 base pairs).

SEQ ID NO: 28 shows the OsLip1 protein sequence for SEQ ID NO: 27 (358 amino acids).

SEQ ID NOs: 29-30 show exemplary TILLING primers that have proven useful in identifying novel mutations within the OsLip1 gene sequence.

SEQ ID Nos: 31-35 show exemplary guide sequences for targeting genome editing of OsLip1.

SEQ ID NO. 36 shows the rice OsLip1 protein sequence.

SEQ ID NO. 37 shows the wheat Lip-A1 protein sequence.

SEQ ID NO. 38 shows the wheat Lip-B1 protein sequence.

SEQ ID NO. 39 shows the wheat Lip-D1 protein sequence.

SEQ ID NO. 40 shows the wheat Lip-A2 protein sequence.

SEQ ID NO. 41 shows the wheat Lip-D2 protein sequence.

SEQ ID NO. 42 shows the wheat Lip-B2.4 protein sequence.

SEQ ID NO. 43 shows the wheat Lip-B2.1 protein sequence.

SEQ ID NO. 44 shows the wheat Lip-B2.2 protein sequence.

SEQ ID NO. 45 shows the wheat Lip-B2.3 protein sequence.

SEQ ID NO. 46 shows the wheat Lip-A3 protein sequence.

SEQ ID NO. 47 shows the wheat Lip-B3 protein sequence.

SEQ ID NO. 48 shows the consensus protein sequence for the rice and wheat lipase protein sequence.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 shows the protein alignment of rice Lipase 1 and wheat Lipases 1, 2 and 3, with SEQ ID NO. 36 showing rice lipase1 (OsLip1), SEQ ID NO. 37 showing wheat Lip-A1 protein sequence, SEQ ID NO. 38 showing wheat Lip-B1 protein sequence, SEQ ID NO. 39 showing wheat Lip-D1 protein sequence, SEQ ID NO. 40 showing wheat Lip-A2 protein sequence, SEQ ID NO. 41 showing wheat Lip-D2 protein sequence, SEQ ID NO. 42 showing wheat Lip-B2.4 protein sequence, SEQ ID NO. 43 showing wheat Lip-B2.1 protein sequence, SEQ ID NO. 44 showing wheat Lip-B2.2 protein sequence, SEQ ID NO. 45 showing wheat Lip-B2.3 protein sequence, SEQ ID NO. 46 showing wheat Lip-A3 protein sequence, SEQ ID NO. 47 showing wheat Lip-B3 protein sequence, and SEQ ID NO. 48 showing the consensus protein sequence for the rice and wheat lipase protein sequence.

FIG. 2 shows the expression of the Lipase 1, 2 and 3 genes in various tissue types of wheat.

FIG. 3 shows the (A) Gene model of Lip-B1 of wheat. Boxes represent exons (numbered) and lines represent introns. Lip-B1 marker primers amplify a 332 bp PCR product in wheat varieties with intact Lip-B1 sequences and a 207 bp band representing Lip-A1 and Lip-D1 in varieties lacking this region of Lip-B1 sequence. (B) PCR products of Lip-B1 marker indicating that many varieties lack Lip-B1 sequence and that CS and Kr contain Lip-B1 sequences. CS— Chinese Spring, Ex—Express, Kr— Kronos, NTC—no template control.

DETAILED DESCRIPTION Definitions

The numerical ranges in this disclosure are approximate, and thus may include values outside of the range unless otherwise indicated. Numerical ranges include all values from and including the lower and the upper values, in increments of one unit, provided that there is a separation of at least two units between any lower value and any higher value. As an example, if a compositional, physical or other property, such as, for example, molecular weight, viscosity, etc., is from 100 to 1,000, it is intended that all individual values, such as 100, 101, 102, etc., and sub ranges, such as 100 to 144, 155 to 170, 197 to 200, etc., are expressly enumerated. For ranges containing values which are less than one or containing fractional numbers greater than one (e.g., 1.1, 1.5, etc.), one unit is considered to be 0.0001, 0.001, 0.01 or 0.1, as appropriate. For ranges containing single digit numbers less than ten (e.g., 1 to 5), one unit is typically considered to be 0.1. These are only examples of what is specifically intended, and all possible combinations of numerical values between the lowest value and the highest value enumerated, are to be considered to be expressly stated in this disclosure. Numerical ranges are provided within this disclosure for, among other things, relative amounts of components in a mixture, and various temperature and other parameter ranges recited in the methods.

As used herein, the term “allele” is any of one or more alternative forms of a gene, all of which relate to one trait or characteristic. In a diploid cell or organism, the two alleles of a given gene occupy corresponding loci on a pair of homologous chromosomes. An allele can be “wild-type” indicating the parental sequence at a particular nucleotide position, or “mutant” indicating a different nucleotide than the parental sequence. The term “heterozygous” indicates one wild-type and one mutant allele at a particular nucleotide position, and the term “homozygous” indicates two of the same allele at a particular nucleotide position.

As used herein, the terms “altering”, “increasing”, “increased”, “reducing”, “reduced”, “inhibited” or the like are considered relative terms, i.e. in comparison with the wild-type or unaltered state. The “level of a protein” refers to the amount of a particular protein, for example Lip1, which may be measured by any means known in the art such as, for example, Western blot analysis, or mass spectrometry or other immunological means. The “level of an enzyme activity” refers to the amount of a particular enzyme measured in an enzyme assay. It would be appreciated that the level of activity of an enzyme might be altered in a mutant but not the expression level (amount) of the protein itself. Conversely, the amount of protein might be altered but the activity remain the same if a more or less active protein is produced. Reductions in both amount and activity are also possible such as, for example, when a gene encoding the enzyme is inactivated. In certain embodiments, the reduction in the level of protein or activity is by at least 10% or by at least 20% or by at least 30% or by at least 40% or by at least 50% or by at least 60% compared to the level of protein or activity in the endosperm of the unmodified plant, or by at least 70%, or by at least 80% or by at least 85% or by at least 90% or at least 95%. The reduction in the level of the protein or enzyme activity or gene expression may occur at any stage in the development of the grain, particularly during the grain filling stage, or at all stages of grain development through to maturity.

As used herein, amino acid or nucleotide sequence “identity” and “similarity” are determined from an optimal global alignment between the two sequences being compared. An optimal global alignment is achieved using, for example, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48:443-453). Sequences may also be aligned using algorithms known in the art including but not limited to CLUSTAL V algorithm or the BLASTN or BLAST 2 sequence programs.

“Identity” means that an amino acid or nucleotide at a particular position in a first polypeptide or polynucleotide is identical to a corresponding amino acid or nucleotide in a second polypeptide or polynucleotide that is in an optimal global alignment with the first polypeptide or polynucleotide. In contrast to identity, “similarity” encompasses amino acids that are conservative substitutions. A “conservative” substitution is any substitution that has a positive score in the Blosum62 substitution matrix (Henikoff and Henikoff, 1992, Proc. Natl. Acad. Sci. USA 89: 10915-10919).

By the statement “sequence A is n % similar to sequence B,” it is meant that n % of the positions of an optimal global alignment between sequences A and B consists of identical residues or nucleotides and conservative substitutions. By the statement “sequence A is n % identical to sequence B,” it is meant that n % of the positions of an optimal global alignment between sequences A and B consists of identical residues or nucleotides.

As used herein, “hydrolytic stability” refers to the conversion of tri-acylglycerides (TAG) into non-esterified or free fatty acids (FFA). An increase or improvement in hydrolytic stability refers to a reduction in the rate of TAG conversion to FFA.

As used herein, “hydrolytic rancidity” refers to the odor or flavor that develops when triglycerides are hydrolyzed and free fatty acids are released. In some embodiments, rancidity in foods may be very slight, indicated by a loss of freshness. In other embodiments, rancidity in foods may be very severe, indicated by objectionable odors and/or flavors.

As used herein, “increase in shelf life” refers to an increase in the time period for which the product can remain sellable or useable. For example, millers commonly stamp ‘use by’ dates after milling for whole grain flour in the United States. A typical “use by” date may be four months. An “increase in shelf life” would extend the use by date as compared to a typical product. In some embodiments, an “increase in shelf life” may also refer to the reduction in accumulation of free fatty acids, or hexanal, or the reduction in objectionable flavors and odors.

As used herein, lipase is an enzyme that catalyzes the hydrolysis of fats (lipids). Lipases are a subclass of the esterases.

As used herein, “oxidative rancidity” refers to the degradation of a product by available oxygen in the air. Not to be bound by a particular theory, the double bonds of an unsaturated fatty acid can undergo cleavage, via a free radical process, releasing volatile aldehydes and ketones. Oxidation primarily occurs with unsaturated fats.

As used herein, an increase or improvement in “oxidative stability” refers to a reduction in the rate of degradation of a product by available oxygen.

As used herein, the term “plant” includes reference to an immature or mature whole plant, including a plant from which seed or grain or anthers have been removed. A seed or embryo that will produce the plant is also considered to be the plant. As used herein, the term plant encompasses cereals including but not limited to wheat and rice.

As used herein, the term “plant parts” includes plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clumps, and plant cells that are intact in plants or parts of plants, such as embryos, pollen, ovules, pericarp, seed, flowers, florets, heads, spikes, leaves, roots, root tips, anthers, and the like.

As used herein, the term “polypeptide(s)” refers to any peptide or protein comprising two or more amino acids joined to each other by peptide bonds or modified peptide bonds. “Polypeptide(s)” refers to both short chains, commonly referred to as peptides, oligopeptides and oligomers, and to longer chains generally referred to as proteins. Polypeptides may contain amino acids other than the 20 gene-encoded amino acids. “Polypeptide(s)” include those modified either by natural processes, such as processing and other post-translational modifications, but also by chemical modification techniques. Such modifications are well described in basic texts and in more detailed monographs, as well as in a voluminous research literature and they are well known to those of skill in the art. It will be appreciated that the same type of modification may be present in the same or varying degree at several sites in a given polypeptide.

As used herein, an “Lip1 derivative” refers to a Lip1 protein/peptide/polypeptide sequence that possesses biological activity that is substantially reduced as compared to the biological activity of the whole Lip1 protein/peptide/polypeptide sequence. In other words, it refers to a polypeptide of a modified Lip1 protein that has reduced Lip1 enzymatic activity. The term “Lip11 derivative” encompasses the “fragments” or “chemical derivatives” of a modified Lip1 protein/peptide.

As used herein, the term “polynucleotide(s)” generally refers to any polyribonucleotide or poly-deoxyribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA. This definition includes, without limitation, single- and double-stranded DNA, DNA that is a mixture of single- and double-stranded regions or single-, double- and triple-stranded regions, cDNA, single- and double-stranded RNA, and RNA that is a mixture of single- and double-stranded regions, hybrid molecules comprising DNA and RNA that may be single-stranded or, more typically, double-stranded, or triple-stranded regions, or a mixture of single- and double-stranded regions. The term “polynucleotide(s)” also embraces short nucleotides or fragments, often referred to as “oligonucleotides,” that due to mutagenesis are not 100% identical but nevertheless code for the same amino acid sequence.

A “reduced or non-functional fragment,” as is used herein, refers to a nucleic acid sequence that encodes for a Lip1 protein that has reduced biological activity as compared the protein coding of the whole nucleic acid sequence. In other words, it refers to a nucleic acid or fragment(s) thereof that substantially retains the capacity of encoding a Lip1 polypeptide of the invention, but the encoded Lip1 polypeptide has reduced activity.

The term “fragment,” as used herein, refers to a polynucleotide sequence, (e.g., a PCR fragment) which is an isolated portion of the subject nucleic acid constructed artificially (e.g., by chemical synthesis) or by cleaving a natural product into multiple pieces, using restriction endonucleases or mechanical shearing, or a portion of a nucleic acid synthesized by PCR, DNA polymerase or any other polymerizing technique well known in the art, or expressed in a host cell by recombinant nucleic acid technology well known to one of skill in the art.

With reference to polynucleotides of the disclosure, the term “isolated polynucleotide” is sometimes used. This term, when applied to DNA, refers to a DNA molecule that is separated from sequences with which it is immediately contiguous (in the 5′ and 3′ directions) in the naturally occurring genome of the organism from which it was derived. For example, the “isolated polynucleotide” may comprise a PCR fragment.

In another embodiment, the “isolated polynucleotide” may comprise a DNA molecule inserted into a vector, such as a plasmid or virus vector, or integrated into the genomic DNA of a prokaryote or eukaryote. An “isolated polynucleotide molecule” may also comprise a cDNA molecule.

In another embodiment, the term “isolated polynucleotide” may comprise RNA. In another embodiment, the term “isolated polynucleotide” may comprise exome captured DNA (King, Robert, et al. Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing. PloS one 10.9 (2015): e0137549).

A wheat plant is defined herein as any plant of a species of the genus Triticum, which species is commercially cultivated, including, for example, Triticum aestivum L. ssp. aestivum (common or bread wheat), other subspecies of Triticum aestivum, Triticum turgidum L. ssp. durum (durum wheat, also known as macaroni or hard wheat), Triticum monococcum L. ssp. monococcum (cultivated einkorn or small spelt), Triticum timopheevi ssp. timopheevi, Triticum turgigum L. ssp. dicoccon (cultivated emmer), and other subspecies of Triticum turgidum (Feldman). The wheat may be hexaploid wheat having an AABBDD type genome, or tetraploid wheat having an AABB type genome. Since genetic variation in wheat transferred to certain related species, including rye and barley by hybridization, the disclosure also includes the hybrid species thus formed, including triticale that is a hybrid between bread wheat and rye. In one embodiment, the wheat plant is of the species Triticum aestivum, and preferably of the subspecies aestivum. Alternatively, since mutations or transgenes can be readily transferred from Triticum aestivum to durum wheat, the wheat is preferably Triticum turgidum L. ssp. Durum.

A rice plant is defined herein as any plant of a species of the genus Oryza, which species is commercially cultivated, including, for example, Oryza sativa L. indica and Oryza sativa L. japonica and other species such as Oryza sativa L. tropical japonica Oryza rufipogon. In one embodiment, the rice plant is of the species Oryza sativa, and preferably of the subspecies indica. Mutations or transgenes can be readily transferred from Oryza sativa indica to japonica and other rice species.

In one embodiment, the disclosure relates to non-transgenic mutations in one or more Lip1 genes of a plant. In another embodiment, the disclosure describes plants exhibiting seeds with deceased Lip1 activity as compared to wild type seeds without the inclusion of foreign nucleic acids in the plant genome. In yet another embodiment, the disclosure describes plants exhibiting seeds with increased oxidative stability as compared to wild type seeds, without the inclusion of foreign nucleic acids in the plant genome. In yet another embodiment, the disclosure describes plants exhibiting seeds with increased hydrolytic stability as compared to wild type seeds, without the inclusion of foreign nucleic acids in the plant genome.

In yet another embodiment, the disclosure describes plants exhibiting seeds producing flour and/or bran with increased shelf life as compared to wild type seeds, without the inclusion of foreign nucleic acids in the wheat plant genome.

In still another embodiment, the disclosure relates to a series of independent human-induced non-transgenic mutations in one or more Lip1 genes of a plant; plants having one or more of these mutations in at least one Lip1 gene thereof, and a method of creating and identifying similar and/or additional mutations in at least one Lip1 gene of a plant. Additionally, the disclosure relates to plants exhibiting plant products with decreased Lip1 activity and/or increased oxidative stability and/or increased hydrolytic stability and/or shelf life as compared to wild type plant products without the inclusion of foreign nucleic acids in the plants' genomes.

I. Lip1 Mutations

A. Lip1 Genes

In one embodiment, the disclosure relates to one or more non-transgenic mutations in the Lip1 gene of a plant. In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip1 gene of a plant including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

In another embodiment, the Lip1 gene of a plant may contain one or more non-transgenic mutations recited in Tables 1, 2, 3, and 4 and corresponding mutations in homoeologues and combinations thereof.

In another embodiment, the disclosure relates to corresponding mutations to the one or more non-transgenic mutations disclosed herein in the Lip1 gene in a corresponding homoeologue. By way of example, an identified mutation in the Lip-A1 gene of the A genome of a wheat plant may be a beneficial mutation in the Lip1 gene of the B and/or D genome. One of ordinary skill in the art will understand that the mutation in the homoeologue may not be in the exact location.

One of ordinary skill in the art understands there is natural variation in the genetic sequences of the Lip1 genes in different varieties of a specific plant.

1. Wheat Plants

The inventors have determined mutations that reduce Lip1 gene function are desired in order to improve the shelf of wheat products, including but not limited to wheat whole grain flour. Preferred mutations include missense and nonsense changes, including mutations that prematurely truncate the translation of one or more Lip1 proteins from messenger RNA, such as those mutations that create a stop codon within the coding region of an Lip1 messenger RNA. Such mutations include insertions, deletions, repeat sequences, splice junction mutations, modified open reading frames (ORFs) and point mutations. Some stop codon mutations are more effective than others because not all stop codon mutations reduce lipase activity to the same extent.

In still another embodiment, one or more mutations are in the Lip-A1 gene of the A genome. In still another embodiment, one or more mutations are in the Lip-D1 gene of the D genome. In another embodiment, one or more mutations are in the Lip-A1 and Lip-D1 genes of the A and D genomes.

In still another embodiment, one or more mutations are in the Lip-A1 gene of the A genome. In still another embodiment, one or more mutations are in the Lip-B1 gene of the B genome. In another embodiment, one or more mutations are in the Lip-A1 and Lip-B1 genes of the A and B genomes.

a. A Genome

In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip1 gene of the A genome including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations. In one embodiment, one or more non-transgenic mutations are in both alleles of the Lip1 gene in the A genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip1 gene of the A genome.

The following mutations identified in Tables 1, 2, 3, and 4 are exemplary of the mutations created and identified according to various embodiments disclosed herein. They are offered by way of illustration, not limitation. It is to be understood that the mutations below are merely exemplary and that similar mutations are also contemplated.

One exemplary mutation in Table 1 is G2141A, resulting in a change from guanine (wild-type allele) to adenine (mutant allele) at nucleotide position 2141 identified according to its position in the sequence of Lip-A1 SEQ ID NO: 1. This mutation results in a change from a tryptophan to a stop (*) codon at amino acid position 122 (W122*) identified according to its position in the expressed protein of Lip-A1 (SEQ ID NO: 3).

Table 1 provides examples of mutations created and identified in Lip-A1 in the A genome of wheat plants, variety Express. Nucleotide and amino acid changes are identified according to their positions in SEQ ID NOs: 1 and 3, respectively.

TABLE 1 Representative mutation alleles in the Lip-A1 gene in the A genome Primer Nucleotide SEQ ID Mutation (SEQ A.A Mutation NOs Line Gene ID NO: 1) (SEQ ID NO: 3) 10, 11  1 Lip-A1 C1970T A104V 10, 11  2 Lip-A1 C2328T A153V 10, 11  3 Lip-A1 C2352T A161V 10, 11  4 Lip-A1 C2682T A214V 10, 11  5 Lip-A1 G1927A A90T 10, 11  6 Lip-A1 C1928T A90V 10, 11  7 Lip-A1 G1942A A95T 10, 11  8 Lip-A1 G1519A C65Y 10, 11  9 Lip-A1 G1791A C87Y 10, 11 10 Lip-A1 G1319A D38N 10, 11 11 Lip-A1 G1491A D56N 10, 11 12 Lip-A1 G1987A E110K 10, 11 13 Lip-A1 G2931A E267K 10, 11 14 Lip-A1 G2289A G140E 10, 11 15 Lip-A1 G2402A G178R 10, 11 16 Lip-A1 G2406A G179E 10, 11 17 Lip-A1 G2405A G179R 10, 11 18 Lip-A1 G2730A G230E 10, 11 19 Lip-A1 C2747T H236Y 10, 11 20 Lip-A1 C2789T H250Y 10, 11 21 Lip-A1 C2148T L125F 10, 11 22 Lip-A1 C2435T L189F 10, 11 23 Lip-A1 C1328T L41F 10, 11 24 Lip-A1 C2163T P130S 10, 11 25 Lip-A1 C2172T P133S 10, 11 26 Lip-A1 C2705T P222S 10, 11 27 Lip-A1 C2754T P238L 10, 11 28 Lip-A1 C2756T P239S 10, 11 29 Lip-A1 G2322A R151H 10, 11 30 Lip-A1 G2355A R162K 10, 11 31 Lip-A1 G2718A R226Q 10, 11 32 Lip-A1 G2802A R254K 10, 11 33 Lip-A1 G1764A R78K 10, 11 34 Lip-A1 G2158A S128N 10, 11 35 Lip-A1 C2298T S143F 10, 11 36 Lip-A1 G2625A S195N 10, 11 37 Lip-A1 C2914T S261F 10, 11 38 Lip-A1 G2184A Splice Junction 10, 11 39 Lip-A1 G2807A Splice Junction 10, 11 40 Lip-A1 G1799A Splice Junction 10, 11 41 Lip-A1 C2313T T148I 10, 11 42 Lip-A1 C2361T T164I 10, 11 43 Lip-A1 G2136A V121I 10, 11 44 Lip-A1 G2633A V198I 10, 11 45 Lip-A1 G2723A V228I 10, 11 46 Lip-A1 G1781A V84M 10, 11 47 Lip-A1 G2140A W122* 10, 11 48 Lip-A1 G2141A W122* 10, 11 49 Lip-A1 G2902A W257* 10, 11 50 Lip-A1 G2903A W257* 10, 11 51 Lip-A1 G1514A W63*

In one embodiment, the disclosure relates to a polynucleotide of the Lip1-A1 gene in the A genome with one or more non-transgenic mutations listed in Table 1 and corresponding to SEQ ID NO: 1. In another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 1 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 1. In yet another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 1 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 1.

In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 1 codes for a Lip-A1 protein, wherein the Lip-A1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 3. In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 1 codes for a Lip-A1 protein, wherein the Lip-A1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 3.

b. D Genome

In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip-D1 gene of the D genome including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations. In one embodiment, one or more non-transgenic mutations are in both alleles of the Lip-D1 gene in the D genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip-D1 gene of the D genome.

In one embodiment, one or more mutations are in the Lip-D1 gene of the D genome. In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip-D1 gene including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

One exemplary mutation in Table 2 is C1780T, resulting in a change from cytosine in the wild-type sequence to a thymine in the mutant sequence at nucleotide position 1780 identified according to its position in the sequence of Lip-D1 SEQ ID NO: 4. This mutation results in a change of a glutamate to a stop (*) codon at amino acid position 88 (Q88*) identified according to its position in the expressed Lip-D1 protein (SEQ ID NO: 6).

Table 2 provides representative examples of mutations created and identified in Lip-D1 in the D genome of wheat plants, variety Express. Nucleotide and amino acid changes are identified according to their positions in SEQ TD NOs: 4 and 6, respectively.

TABLE 2 Representative mutation alleles in the Lip-D1 gene in the D genome Primer Nucleotide A.A Mutation SEQ ID Mutation (SEQ (SEQ ID NOs Line Gene ID NO: 4) NO: 6) 12, 13 1 Lip-D1 G2162A A134T 12, 13 2 Lip-D1 G2310A A152T 12, 13 3 Lip-D1 C2323T A156V 12, 13 4 Lip-D1 C2398T A181V 12, 13 5 Lip-D1 C2401T A182V 12, 13 6 Lip-D1 G2421A A189T 12, 13 7 Lip-D1 C2663T A213V 12, 13 8 Lip-D1 C2675T A217V 12, 13 9 Lip-D1 G1337A A48T 12, 13 10 Lip-D1 G1343A A50T 12, 13 11 Lip-D1 G1512A C67Y 12, 13 12 Lip-D1 G1775A C86Y 12, 13 13 Lip-D1 G2352A D166N 12, 13 14 Lip-D1 G1735A D73N 12, 13 15 Lip-D1 G1971A E109K 12, 13 16 Lip-D1 G1331A E46K 12, 13 17 Lip-D1 G1768A E84K 12, 13 18 Lip-D1 G2350A G165E 12, 13 19 Lip-D1 G2374A G173E 12, 13 20 Lip-D1 G2373A G173R 12, 13 21 Lip-D1 G2385A G177R 12, 13 22 Lip-D1 G2602A G193R 12, 13 23 Lip-D1 G2633A G203E 12, 13 24 Lip-D1 G2648A G208D 12, 13 25 Lip-D1 C2728T H235Y 12, 13 26 Lip-D1 C1929T H95Y 12, 13 27 Lip-D1 A2892G I257V 12, 13 28 Lip-D1 T1299C I35T 12, 13 29 Lip-D1 C2132T L124F 12, 13 30 Lip-D1 C2599T L192F 12, 13 31 Lip-D1 C2620T L199F 12, 13 32 Lip-D1 C1295T L34F 12, 13 33 Lip-D1 C1313T L40F 12, 13 34 Lip-D1 G2384A M176I 12, 13 35 Lip-D1 G1471A M53I 12, 13 36 Lip-D1 C2147T P129S 12, 13 37 Lip-D1 C2156T P132S 12, 13 38 Lip-D1 C2686T P221S 12, 13 39 Lip-D1 C2779T P252S 12, 13 40 Lip-D1 C1780T Q88* 12, 13 41 Lip-D1 C2304T R150C 12, 13 42 Lip-D1 G2338A R161K 12, 13 43 Lip-D1 C2641T R206C 12, 13 44 Lip-D1 G1978A S111N 12, 13 45 Lip-D1 G2142A S127N 12, 13 46 Lip-D1 G2269A S138N 12, 13 47 Lip-D1 C2281T S142F 12, 13 48 Lip-D1 C2284T S143F 12, 13 49 Lip-D1 G2606A S194N 12, 13 50 Lip-D1 C2747T S241F 12, 13 51 Lip-D1 C1275T S27F 12, 13 52 Lip-D1 G1783A Splice Junction 12, 13 53 Lip-D1 G2788A Splice Junction 12, 13 54 Lip-D1 G2261A Splice Junction 12, 13 55 Lip-D1 G2885A Splice Junction 12, 13 56 Lip-D1 G2168A Splice Junction 12, 13 57 Lip-D1 G1346A Splice Junction 12, 13 58 Lip-D1 G1979A Splice Junction 12, 13 59 Lip-D1 C2627T T201I 12, 13 60 Lip-D1 C1473T T54I 12, 13 61 Lip-D1 G2683A V220M 12, 13 62 Lip-D1 G2722A V233M 12, 13 63 Lip-D1 G2107A W115* 12, 13 64 Lip-D1 G2125A W121* 12, 13 65 Lip-D1 G1498A W62* 12, 13 66 Lip-D1 G1497A W62*

In one embodiment, the invention relates to a polynucleotide of the Lip 1 gene in the D genome with one or more non-transgenic mutations listed in Table 2 and corresponding to SEQ ID NO: 4. In another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 2 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 4. In yet another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 2 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 4.

In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 2 codes for a Lip-D1 protein, wherein the Lip-D1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 6. In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 2 codes for a Lip-D1 protein, wherein the Lip-D1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 6.

c. B Genome

In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip-B1 gene of the B genome including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations. In one embodiment, one or more non-transgenic mutations are in both alleles of the Lip-B1 gene in the B genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip-B1 gene of the B genome.

In one embodiment, one or more mutations are in the Lip-B1 gene of the B genome. In one embodiment, the disclosure relates to multiple non-transgenic mutations in the Lip-B1 gene including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations.

One exemplary mutation in Table 3 is G2299A, resulting in a change from guanine in the wild-type sequence to an adenine in the mutant sequence at nucleotide position 2299 identified according to its position in the sequence of Lip-B1 SEQ ID NO: 7. This mutation results in a change of a tryptophan to a stop (*) codon at amino acid position 116 (W116*) identified according to its position in the expressed Lip-B1 protein (SEQ ID NO: 9).

Table 3 provides representative examples of mutations created and identified in Lip-B1 in the B genome of wheat plants, variety Kronos. Nucleotide and amino acid changes are identified according to their positions in SEQ ID NOs: 7 and 9, respectively.

TABLE 3 Representative mutation alleles in the Lip-B1 gene in the B genome Primer Nucleotide A.A Mutation SEQ ID Mutation (SEQ (SEQ ID NOs Line Gene ID NO: 7) NO: 9) 14, 15  1 Lip-B1 T1560A Y61N 14, 15  2 Lip-B1 C1599A Splice Junction 14, 15  3 Lip-B1 C1947T S79F 14, 15  4 Lip-B1 G1964A E85K 14, 15  5 Lip-B1 C2123T A95V 14, 15  6 Lip-B1 C2150T A104V 14, 15  7 Lip-B1 G2156A R106K 14, 15  8 Lip-B1 G2299A W116* 14, 15  9 Lip-B1 G2334A S128N 14, 15 10 Lip-B1 G2515A A157T 14, 15 11 Lip-B1 C2528T A161V 14, 15 12 Lip-B1 G2543A G166E 14, 15 13 Lip-B1 C2569T H175Y 14, 15 14 Lip-B1 G2578A G178R 14, 15 15 Lip-B1 G2801A D196N 14, 15 16 Lip-B1 C2813T L200F 14, 15 17 Lip-B1 C2831T P206S 14, 15 18 Lip-B1 C2856T A214V

In one embodiment, the disclosure relates to a polynucleotide of the Lip1 gene in the B genome with one or more non-transgenic mutations listed in Table 3 and corresponding to SEQ ID NO: 7. In another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 3 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 7. In yet another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 2 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 7.

In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 3 codes for a Lip-B1 protein, wherein the Lip-B1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 9. In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 3 codes for a Lip-B1 protein, wherein the Lip-B1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 9.

2. Rice Plants

One of ordinary skill in the art understands there is natural variation in the genetic sequences of the Lip1 genes in different rice varieties. In one embodiment, one or more mutations are in the OsLip1 gene. In one embodiment, the disclosure relates to multiple non-transgenic mutations in the OsLip1 gene including but not limited to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and greater than 10 mutations. In one embodiment, one or more non-transgenic mutations are in both alleles of the OsLip1 gene. In another embodiment, the non-transgenic mutations are identical in both alleles of the OsLip1 gene.

One exemplary mutation in Table 4 is T3424A, resulting in a change from thymine in the wild-type sequence to adenine in the mutant sequence at nucleotide position 3424 identified according to its position in the sequence of OsLip1 SEQ ID NO: 26. This mutation results in a change of a tyrosine to a stop (*) codon at amino acid position 156 (Y156*) identified according to its position in the expressed OsLip1 protein (SEQ ID NO: 28).

Table 4 provides representative examples of mutations created and identified in OsLip1 of rice plants. Nucleotide and amino acid changes are identified according to their positions in SEQ ID NOs: 26 and 28, respectively.

TABLE 4 Representative mutation alleles in the OsLip1 gene Primer Nucleotide A.A Mutation SEQ ID Mutation (SEQ (SEQ ID NOs Line Gene ID NO: 26) NO: 28) 29, 30 1 OsLip1 A2629T T73S 29, 30 2 OsLip1 T3280C M143T 29, 30 3 OsLip1 T2358A L46* 29, 30 4 OsLip1 T2632A W74R 29, 30 5 OsLip1 T2666A Splice Junction 29, 30 6 OsLip1 A2943T D94V 29, 30 7 OsLip1 T3424A Y156* 29, 30 8 OsLip1 A3467T K171*

In one embodiment, the disclosure relates to a polynucleotide of the OsLip1 gene with one or more non-transgenic mutations listed in Table 4 and corresponding to SEQ ID NO: 26. In another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 4 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 26.

In yet another embodiment, the polynucleotide with one or more non-transgenic mutations listed in Table 4 is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 26.

In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 4 codes for an OsLip1 protein, wherein the OsLip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical to SEQ ID NO: 28. In still another embodiment, the polynucleotide with one or more non-transgenic mutation listed in Table 4 codes for an OsLip1 protein, wherein the OsLip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% similar to SEQ ID NO: 28.

B. Lip1 Proteins

In yet another embodiment, the disclosure relates to one or more non-transgenic mutations in the Lip1 genes (as discussed above in the section entitled Lip1 Mutations) that result in an Lip1 protein with one or more mutations as compared to wild type Lip1 protein. In one embodiment, the non-transgenic mutations include but are not limited to the mutations recited in Tables 1-3 for wheat and Table 4 for rice, corresponding mutations in homoeologues, and combinations thereof.

In another embodiment, the disclosure relates to one or more non-transgenic mutations in the Lip1 gene or promoter that inhibits production of the Lip1 protein. In some embodiments, a mutation in the Lip1 gene or promoter reduces expression of the Lip1 protein. In other embodiments, a mutation in the Lip1 gene or promoter creates an unstable or reduced function Lip1 protein. In another embodiment, the non-transgenic mutations include but are not limited to the mutations recited in Tables 1-3 for wheat and Table 4 for rice, corresponding mutations in homoeologues, and combinations thereof.

1. Expression Level of Lip1 Proteins

In another embodiment, the expression level of Lip1 proteins with one or more mutations disclosed herein is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, and 95-99% of the expression level of the wild type Lip1 protein.

In yet another embodiment, the expression level of Lip-A1 protein with one or more mutations disclosed herein is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, and 95-99% of the expression level of the wild type Lip-A1 protein.

In still another embodiment, the expression level of Lip-D1 protein with one or more mutations disclosed herein is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, and 95-99% of the expression level of the wild type Lip-D1 protein.

In still another embodiment, the expression level of Lip-B1 protein with one or more mutations disclosed herein is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, and 95-99% of the expression level of the wild type Lip-B1 protein.

In still another embodiment, the expression level of OsLip1 protein with one or more mutations disclosed herein is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, and 95-99% of the expression level of the wild type OsLip1 protein.

2. Activity of Lip1 Proteins

In yet another embodiment, the lipase activity of the Lip1 protein with one or more mutations disclosed herein is reduced to 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% of the activity level of the wild type Lip1 protein. In another embodiment, the Lip1 protein with one or more mutations disclosed herein has no activity or zero activity as compared to wild type Lip1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein with one or more mutations disclosed herein is from 0-10% or from 10-30% or from 30-50% or from 50-70% or from 70-80% or from 80-90% or from 90-95% of the activity level of the wild type Lip1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-A1 gene with one or more mutations disclosed herein is reduced to 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% of the activity level of the wild type Lip-A1 protein. In another embodiment, the Lip-A1 protein with one or more mutations disclosed herein has no activity or zero activity as compared to wild type Lip-A1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-A1 gene with one or more mutations disclosed herein is from 0-10% or from 10-30% or from 30-50% or from 50-70% or from 70-80% or from 80-90% or from 90-95% of the activity level of the wild type Lip-A1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-D1 gene with one or more mutations disclosed herein is reduced to 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% of the activity level of the wild type Lip-D1 protein. In another embodiment, the Lip-D1 protein with one or more mutations disclosed herein has no activity or zero activity as compared to wild type Lip-D1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-D1 gene with one or more mutations disclosed herein is from 0-10% or from 10-30% or from 30-50% or from 50-70% or from 70-80% or from 80-90% or from 90-95% of the activity level of the wild type Lip-D1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-B1 gene with one or more mutations disclosed herein is reduced to 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% of the activity level of the wild type Lip-B1 protein. In another embodiment, the Lip-B1 protein with one or more mutations disclosed herein has no activity or zero activity as compared to wild type Lip-B1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the Lip-B1 gene with one or more mutations disclosed herein is from 0-10% or from 10-30% or from 30-50% or from 50-70% or from 70-80% or from 80-90% or from 90-95% of the activity level of the wild type Lip-B1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the OsLip1 gene with one or more mutations disclosed herein is reduced to 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% of the activity level of the wild type OsLip1 protein. In another embodiment, the OsLip1 protein with one or more mutations disclosed herein has no activity or zero activity as compared to wild type OsLip1 protein.

In yet another embodiment, the lipase activity of the Lip1 protein from the OsLip1 gene with one or more mutations disclosed herein is from 0-10% or from 10-30% or from 30-50% or from 50-70% or from 70-80% or from 80-90% or from 90-95% of the activity level of the wild type OsLip1 protein.

II. Hydrolytic Stability; Oxidative Stability; Increased Shelf Life

In yet another embodiment, the disclosure relates to one or more non-transgenic mutations in a Lip1 gene of plant (as discussed above in the section entitled Lip1 Mutations) that results in increased shelf life of a plant product. In yet another embodiment, the disclosure relates to one or more non-transgenic mutations in a Lip1 gene in a plant (as discussed above in the section entitled Lip1 Mutations) that results in increased stability of products made from the grains or seeds of said plant with one or more Lip1 mutations as compared to products made from wild type grains or seeds. In one embodiment, the non-transgenic mutations include but are not limited to the mutations recited in Tables 1-4, corresponding mutations in homoeologues, and combinations thereof.

In yet another embodiment, the shelf life of whole grain flour made from wheat grains with one or more Lip1 mutations disclosed herein is increased from the typical shelf life of whole grain flour. Millers commonly stamp ‘use by’ dates of 3-9 months after milling for whole grain flour in the United States, but this shelf life can be reduced to 1-3 months by high storage temperatures and humidity. Shelf life can be determined by sensory characteristics of the flour and products made from it including color, flavor, texture, aroma, performance or overall preference of the finished product. Trained panelists can be used to assess differences between materials.

In yet another embodiment, shelf life of whole grain flour made from wheat grain with one or more mutations disclosed herein is increased by 1-9 months, or 2-10 months, or 3-11 months, or 4-12 months, or 5-13 months, or 6-14 months, or 7-15 months, or 8-16 months, or 9-17 months, or 10-18 months or 11-19 months, or 12-20 months, or 13-21 months, or 14-22 months, or 15-23 or 16-24 months as compared to the shelf life of whole grain flour made from wild-type grain.

In yet another embodiment, shelf life of whole grain flour made from wheat grain with one or more mutations disclosed herein is increased by 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, 12 months, 13 months, 14 months, 15 months, 16 months, 17 months, 18 months, 19 months, 20 months, 21 months, 22 months, 23 months, 24 months, 25 months, 26 months, 27 months, 28 months, 29 months, 30 months, or greater than 30 months as compared to the shelf life of whole grain flour made from wild-type grain.

In yet another embodiment, the hydrolytic stability and/or oxidative stability of whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein is increased due to decreased production of the decomposition products of fatty acids that can affect the smell or flavor of the product. Not to be bound by any particular theory, the stability of whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein is increased due to the decreased production of the decomposition products of fatty acids.

In yet another embodiment, whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein display decreased production of decomposition products of fatty acids, including but not limited to hexanal, or nonenal, or trihydroxydecanoic acid.

In still another embodiment, whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein display a decrease in production of decomposition products of fatty acids, wherein said decrease is by 0-1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 86, 97, 98, 99% and by more than 99% as compared to the production of degradation products of fatty acids in whole grain flour made from the wild-type grain or rice bran made from wild type rice grain.

In another embodiment, whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein display a decreased production of decomposition products of fatty acids, including but not limited to hexanal, or nonenal, or trihydroxydecanoic acid, wherein the decreased production is from 1% to 5%, or from 5% to 10%, or from 10% to 15%, or from 15% to 20%, or from 20% to 25%, or from 25% to 30%, or from 30% to 35%, or from 35% to 40%, or from 40% to 45%, or from 45% to 50%, or from 50% to 55%, or from 55% to 60%, or from 65% to 70%, or from 70% to 75%, or from 75% to 80%, or from 80% to 85%, or from 85% to 90%, or from 90% to 95%, or from 95% to 99%, or by more than 99% as compared to the production of degradation products of fatty acids in whole grain flour made from the wild-type grain or rice bran made from wild type rice grain.

In another embodiment, whole grain flour made from wheat grain with one or more mutations disclosed herein or rice bran made from rice grain with one or more mutations disclosed herein display a decrease in decomposition products of fatty acids, including but not limited to hexanal, or nonenal, or trihydroxydecanoic acid, wherein said decrease is by at least 5%, or at least 10%, or at least 15%, or at least 20%, or at least 25%, or at least 30%, or at least 35%, or at least 40%, or at least 45%, or at least 50%, or at least 55%, or at least 60%, or at least 65%, or at least 70%, or at least 75%, or at least 80%, or at least 85%, or at least 90%, or at least 95% as compared to the production of degradation products of fatty acids in whole grain flour made from the wild-type grain or rice bran made from wild type rice grain.

III. Transgenes

In one embodiment, the disclosure relates to a transgenic plant that comprises a transgene that encodes a polynucleotide, which down-regulates the expression of the Lip1 gene and/or the activity of the Lip1 protein. Examples of such polynucleotides include, but are not limited to, antisense polynucleotide, a sense polynucleotide, a catalytic polynucleotide, an artificial microRNA or a duplex RNA molecule.

In one embodiment, the disclosure relates to a wheat plant comprising a transgene that reduces the expression of the Lip1 gene and/or activity of the Lip1 protein, wherein the wheat plant has grains with improved shelf life as compared to grains from a wild type plant. In another embodiment, the disclosure relates to a rice plant comprising a transgene that reduces the expression of the Lip1 gene and/or activity of the Lip1 protein, wherein the rice plant has grains with improved shelf life as compared to grains from a wild type plant.

A. Antisense Polynucleotides

The term “antisense polynucleotide” shall be taken to refer to a DNA or RNA, or combination thereof, molecule that is complementary to at least a portion of a specific mRNA molecule encoding Lip1 and capable of interfering with a post-transcriptional event such as mRNA translation.

An antisense polynucleotide in a plant will hybridize to a target polynucleotide under physiological conditions. As used herein, the term “an antisense polynucleotide which hybridizes under physiological conditions” means that the polynucleotide (which is fully or partially single stranded) is at least capable of forming a double stranded polynucleotide with mRNA encoding a protein.

Antisense molecules may include sequences that correspond to the structural gene or for sequences that effect control over the gene expression or splicing event. For example, the antisense sequence may correspond to the targeted coding region of Lip1 or the 5′-untranslated region (UTR) or the 3′-UTR or combination of these. It may be complementary in part to intron sequences, which may be spliced out during or after transcription, preferably only to exon sequences of the target gene. In view of the generally greater divergence of the UTRs, targeting these regions provides greater specificity of gene inhibition.

The length of the antisense sequence should be at least 19 contiguous nucleotides, preferably at least 50 nucleotides, and more preferably at least 100, 200, 500 or 1000 nucleotides. The full-length sequence complementary to the entire gene transcript may be used. The length is most preferably 100-2000 nucleotides. The degree of identity of the antisense sequence to the targeted transcript should be at least 90% and more preferably 95-100%. The antisense RNA molecule may of course comprise unrelated sequences, which may function to stabilize the molecule.

B. Catalytic Polynucleotides

The term catalytic polynucleotide/nucleic acid refers to a DNA molecule or DNA-containing molecule (also known in the art as a “deoxyribozyme”) or an RNA or RNA-containing molecule (also known as a “ribozyme”) which specifically recognizes a distinct substrate and catalyzes the chemical modification of this substrate. The nucleic acid bases in the catalytic nucleic acid can be bases A, C, G, T (and U for RNA).

Typically, the catalytic nucleic acid contains an antisense sequence for specific recognition of a target nucleic acid, and a nucleic acid cleaving enzymatic activity (also referred to herein as the “catalytic domain”).

The ribozymes in plants disclosed herein and DNA encoding the ribozymes can be chemically synthesized using methods well known in the art. The ribozymes can also be prepared from a DNA molecule (that upon transcription, yields an RNA molecule) operably linked to an RNA polymerase promoter, e.g., the promoter for T7 RNA polymerase or SP6 RNA polymerase. When the vector also contains an RNA polymerase promoter operably linked to the DNA molecule, the ribozyme can be produced in vitro upon incubation with RNA polymerase and nucleotides. In a separate embodiment, the DNA can be inserted into an expression cassette or transcription cassette. After synthesis, the RNA molecule can be modified by ligation to a DNA molecule having the ability to stabilize the ribozyme and make it resistant to RNase.

As with antisense polynucleotides described herein, the catalytic polynucleotides should also be capable of hybridizing a target nucleic acid molecule (for example mRNA encoding Lip1) under “physiological conditions,” namely those conditions within a plant cell.

C. RNA Interference

RNA interference (RNAi) is particularly useful for specifically inhibiting the production of a particular protein. This technology relies on the presence of dsRNA molecules that contain a sequence that is essentially identical to the mRNA of the gene of interest or part thereof. Conveniently, the dsRNA can be produced from a single promoter in a recombinant vector or host cell, where the sense and anti-sense sequences are flanked by an unrelated sequence which enables the sense and anti-sense sequences to hybridize to form the dsRNA molecule with the unrelated sequence forming a loop structure. The design and production of suitable dsRNA molecules for the present invention is well within the capacity of a person skilled in the art, particularly considering, WO 99/32619, WO 99/53050, WO 99/49029, and WO 01/34815.

In one example, a DNA is introduced that directs the synthesis of an at least partly double stranded (duplex) RNA product(s) with homology to the target gene to be inactivated. The DNA therefore comprises both sense and antisense sequences that, when transcribed into RNA, can hybridize to form the double-stranded RNA region. In a preferred embodiment, the sense and antisense sequences are separated by a spacer region that comprises an intron which, when transcribed into RNA, is spliced out. This arrangement has been shown to result in a higher efficiency of gene silencing. The double-stranded region may comprise one or two RNA molecules, transcribed from either one DNA region or two. The presence of the double stranded molecule is thought to trigger a response from an endogenous plant system that destroys both the double stranded RNA and also the homologous RNA transcript from the target plant gene, efficiently reducing or eliminating the activity of the target gene.

The length of the sense and antisense sequences that hybridize should each be at least 19 contiguous nucleotides, preferably at least 30 or 50 nucleotides, and more preferably at least 100, 200, 500 or 1000 nucleotides. The full-length sequence corresponding to the entire gene transcript may be used. The lengths are most preferably 100-2000 nucleotides. The degree of identity of the sense and antisense sequences to the targeted transcript should be at least 85%, preferably at least 90% and more preferably 95-100%. The RNA molecule may of course comprise unrelated sequences which may function to stabilize the molecule. The RNA molecule may be expressed under the control of a RNA polymerase II or RNA polymerase III promoter. Examples of the latter include tRNA or snRNA promoters.

In one embodiment, small interfering RNA (“siRNA”) molecules comprise a nucleotide sequence that is identical to about 19-21 contiguous nucleotides of the target mRNA. Preferably, the target mRNA sequence commences with the dinucleotide AA, comprises a GC-content of about 30-70% (preferably, 30-60%, more preferably 40-60% and more preferably about 45%-55%), and does not have a high percentage identity to any nucleotide sequence other than the target in the genome of the barley plant in which it is to be introduced, e.g., as determined by standard BLAST search.

Another RNAi approach that may be used is multi-valent RNAi, as described in U.S. Pat. No. 9,200,276, which targets multiple sequences simultaneously that can be delivered through a spray application as opposed to developing a transgenic plant.

D. microRNA

MicroRNA regulation is a clearly specialized branch of the RNA silencing pathway that evolved towards gene regulation, diverging from conventional RNAi/Post transcriptional Gene Silencing (PTGS). MicroRNAs are a specific class of small RNAs that are encoded in gene-like elements organized in a characteristic inverted repeat. When transcribed, microRNA genes give rise to stem-looped precursor RNAs from which the microRNAs are subsequently processed. MicroRNAs are typically about 21 nucleotides in length. The released miRNAs are incorporated into RISC-like complexes containing a particular subset of Argonaute proteins that exert sequence-specific gene repression.

E. Co-Suppression

Another molecular biological approach that may be used is co-suppression. The mechanism of co-suppression is not well understood but is thought to involve post-transcriptional gene silencing (PTGS) and in that regard may be very similar to many examples of antisense suppression. It involves introducing an extra copy of a gene or a fragment thereof into a plant in the sense orientation with respect to a promoter for its expression. The size of the sense fragment, its correspondence to target gene regions, and its degree of sequence identity to the target gene are as for the antisense sequences described above. In some instances the additional copy of the gene sequence interferes with the expression of the target plant gene. Reference is made to WO 97/20936 and EP 0465572 for methods of implementing co-suppression approaches.

IV. Genomic Editing

In one embodiment, the disclosure relates to a plant with reduced expression of the Lip1 gene and/or reduced activity of the Lip1 protein, wherein reduced expression of the Lip1 gene and/or reduced activity of the Lip1 protein is achieved by genomic editing.

In one embodiment, the disclosure relates to a wheat plant with a genomically edited Lip1 gene, wherein the wheat plant has improved shelf life grains as compared to a wild type plant.

Genome editing, or genome editing with engineered nucleases (GEEN), is a type of genetic engineering in which DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases, or “molecular scissors.” The nucleases create specific double-stranded breaks (DSBs) at desired locations in the genome, and harness the cell's endogenous mechanisms to repair the induced break by natural processes of homologous recombination (HR) and nonhomologous end-joining (NHEJ). There are currently four main families of engineered nucleases being used: Zinc finger nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), the CRISPR/Cas system, and engineered meganuclease with a re-engineered homing endonucleases.

A. Zinc Finger Nucleases (ZFNs)

Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms.

ZFNs consist of an engineered zinc finger DNA-binding domain fused to the cleavage domain of the FokI restriction endonuclease. ZFNs can be used to induce double-stranded breaks (DSBs) in specific DNA sequences and thereby promote site-specific homologous recombination with an exogenous template. The exogenous template contains the sequence that is to be introduced into the genome.

Publicly available methods for engineering zinc finger domains include: (1) Context-dependent Assembly (CoDA), (2) Oligomerized Pool Engineering (OPEN), and (3) Modular Assembly.

In one embodiment, the disclosure relates to reducing expression of the Lip1 gene and/or reducing activity of the Lip1 protein using ZFNs.

B. Transcription Activator-Like Effector Nucleases (TALENs)

TALEN is a sequence-specific endonuclease that consists of a transcription activator-like effector (TALE) and a FokI endonuclease. TALE is a DNA-binding protein that has a highly conserved central region with tandem repeat units of 34 amino acids. The base preference for each repeat unit is determined by two amino acid residues called the repeat-variable di-residue (RVD), which recognizes one specific nucleotide in the target DNA, Arrays of DNA-binding repeat units can be customized for targeting specific DNA sequences. As with ZFNs, dimerization of two TALENs on targeted specific sequences in a genome results in FokI-dependent introduction of DSBs, stimulating homology directed repair (HDR) and Non-homologous end joining (NHEJ) repair mechanisms.

In one embodiment, the disclosure relates to reducing expression of the Lip1 gene and/or reducing activity of the Lip1 protein using TALENs.

C. CRISPR/Cas System The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Type II system is an RNA-Guided Endonuclease technology for genome engineering. There are two distinct components to this system: (1) a guide RNA and (2) an endonuclease, in this case the CRISPR associated (Cas) nuclease, Cas9.

The guide RNA is a combination of the endogenous bacterial crRNA and tracrRNA into a single chimeric guide RNA (gRNA) transcript. The gRNA combines the targeting specificity of the crRNA with the scaffolding properties of the tracrRNA into a single transcript. When the gRNA and the Cas9 are expressed in the cell, the genomic target sequence can be modified or permanently disrupted.

The gRNA/Cas9 complex is recruited to the target sequence by the base-pairing between the gRNA sequence and the complementarity to the target sequence in the genomic DNA. For successful binding of Cas9, the genomic target sequence must also contain the correct Protospacer Adjacent Motif (PAM) sequence immediately following the target sequence. The binding of the gRNA/Cas9 complex localizes the Cas9 to the genomic target sequence so that the wild-type Cas9 can cut both strands of DNA causing a Double Strand Break (DSB). Cas9 will cut 3-4 nucleotides upstream of the PAM sequence. A DSB can be repaired through one of two general repair pathways: (1) NHEJ DNA repair pathway or (2) the HDR pathway. The NHEJ repair pathway often results in insertions/deletions (InDels) at the DSB site that can lead to frameshifts and/or premature stop codons, effectively disrupting the open reading frame (ORF) of the targeted gene.

The HDR pathway requires the presence of a repair template, which is used to fix the DSB. HDR faithfully copies the sequence of the repair template to the cut target sequence. Specific nucleotide changes can be introduced into a targeted gene by the use of HDR with a repair template.

In one embodiment, the disclosure relates to reducing expression of the Lip1 gene and/or reducing activity of the Lip1 protein using the CRISPR/cas9 system or similar technology (or a variant of the technology).

D. Meganuclease with Re-Engineered Homing Nuclease

Meganucleases are endodeoxyribonucleases characterized by a large recognition site (double-stranded DNA sequences of 12 to 40 base pairs); as a result this site generally occurs only once in any given genome. For example, the 18-base pair sequence recognized by the I-SceI meganuclease would on average require a genome twenty times the size of the human genome to be found once by chance (although sequences with a single mismatch occur about three times per human-sized genome). Meganucleases are therefore considered to be the most specific naturally occurring restriction enzymes.

Among meganucleases, the LAGLIDADG family of homing endonucleases has become a valuable tool for the study of genomes and genome engineering over the past fifteen years. By modifying their recognition sequence through protein engineering, the targeted sequence can be changed.

In one embodiment, the disclosure relates to reducing expression of the Lip1 gene and/or reducing activity of the Lip1 protein using a meganuclease with a re-engineered homing nuclease.

V. Wheat Cultivars

In one embodiment, a wheat cultivar having at least one Lip gene that is diploid, tetraploid, or hexaploid may be used. In another embodiment, the wheat is Triticum aestivum. In another embodiment, the wheat is Triticum turgidum ssp durum.

In one embodiment, any cultivar of wheat can be used to create mutations in an Lip1 gene. In one embodiment, any cultivar of wheat can be used to create mutations in an Lip-A1 gene. In another embodiment, any cultivar of wheat can be used to create mutations in an Lip-B1 gene. In another embodiment, any cultivar of wheat can be used to create mutations in an Lip-D1 gene.

In one embodiment, any cultivar of wheat can be used as lines to cross Lip1 mutations into different cultivars.

In another embodiment, any cultivar of wheat having at least one Lip1 gene may be used including but not limited to hard red spring wheat, hard white winter wheat, durum wheat, soft white spring wheat, soft white winter wheat, hard red winter wheat, common wheat, splelt wheat, emmer wheat, pasta wheat and turgidum wheat.

In one embodiment, hard red spring wheat includes but is not limited to Bullseye, Cabernet, Cal Rojo, Hank, Joaquin, Kelse, Lariat, Lassik, Malbec, Mika, PR 1404, Redwing, Summit 515, SY 314, Triple IV, Ultra, WB-Patron, WB-Rockland, Yecora Rojo, Accord, Aim, Anza, Baker, Beth Hashita, Bonus, Borah, Brim, Brooks, Buck Pronto, Butte 86, Cavalier, Challenger, Chief, Ciano T79, Colusa, Companion, Copper, Cuyama, Dash 12, Eldon, Enano, Express, Expresso, Jefferson, Genero F81, Grandin, Helena 554, Hollis, Imuris T79, Inia 66R, Jerome, Kern, Len, Marshall, McKay, Nomad, Northwest 10, Oslo, Pavon F76, Pegasus, Pitic 62, Poco Red, Powell, Probrand 711, Probrand 751, Probrand 771, Probrand 775, Probred, Prointa Queguay, Prointa Quintal, Rich, RSI 5, Sagittario, Scarlet, Serra, Shasta, Solano, Spillman, Sprite, Stander, Stellar, Stoa, Success, Summit, Sunstar 2, Sunstar King, Tadinia, Tammy, Tanori 71, Tara 2000, Tempo, Tesia T79, Topic, UI Winchester, Vance, Vandal, W444, Wampum, Wared, WB-Fuzion, Westbred 906R, Westbred 911, Westbred 926, Westbred 936, Westbred Discovery, Westbred Rambo, Yolo, and Zeke.

In another embodiment, hard white wheat includes but is not limited to Blanca Fuerte, Blanca Grande 515, Blanca Royale, Clear White, Patwin, Patwin 515, WB-Cristallo, WB-Paloma, WB-Perla, Alta Blanca, Blanca Grande, Delano, Golden Spike, ID377S, Klasic, Lochsa, Lolo, Macon, Otis, Phoenix, Pima 77, Plata, Pristine, Ramona 50, Siete Cerros 66, Vaiolet, and Winsome.

In yet another embodiment, durum wheat includes but is not limited to Crown, Desert King, Desert King HP, Duraking, Fortissimo, Havasu, Kronos, Maestrale, Normanno, Orita, Platinum, Q-Max, RSI 59, Saragolla, Tango, Tipai, Topper, Utopia, Volante, WB-Mead, Westmore, Aldente, Aldura, Altar 84, Aruba, Bittern, Bravadur, Candura, Cortez, Deluxe, Desert Titan, Durex, Durfort, Eddie, Germains 5003D, Imperial, Kofa, Levante, Matt, Mead, Mexicali 75, Minos, Modoc, Mohawk, Nudura, Ocotillo, Produra, Reva, Ria, Septre, Sky, Tacna, Titan, Trump, Ward, Westbred 803, Westbred 881, Westbred 883, Westbred 1000D, Westbred Laker, Westbred Turbo, and Yavaros 79.

In another embodiment, soft white spring wheat includes but is not limited to Alpowa, Alturas, Babe, Diva, JD, New Dirkwin, Nick, Twin, Whit, Blanca, Bliss, Calorwa, Centennial, Challis, Dirkwin, Eden, Edwall, Fielder, Fieldwin, Jubilee, Louise, Owens, Penawawa, Pomerelle, Sterling, Sunstar Promise, Super Dirkwin, Treasure, UI Cataldo, UI Pettit, Urquie, Vanna, Waduel, Waduel 94, Wakanz, Walladay, Wawawai, Whitebird, and Zak.

In still another embodiment, soft white winter wheat includes but is not limited to AP Badger, AP Legacy, Brundage 96, Bruneau, Cara, Goetze, Legion, Mary, Skiles, Stephens, SY Ovation, Tubbs, WB-Junction, WB-528, Xerpha, Yamhill, Barbee, Basin, Bitterroot, Bruehl, Castan, Chukar, Coda, Daws, Edwin, Eltan, Faro, Finch, Foote, Gene, Hill 81, Hiller, Hubbard, Hyak, Hyslop, Idaho 587, Kmor, Lambert, Lewjain, MacVicar, Madsen, Malcolm, Masami, McDermid, Moro, Nugaines, ORCF-101, ORCF-102, ORCF-103, Rod, Rohde, Rulo, Simon, Salute, Temple, Tres, Tubbs 06, UICF-Brundage, WB-523, and Weatherford.

In another embodiment, hard red winter wheat includes but is not limited to Andrews, Archer, Batum, Blizzard, Bonneville, Boundary, Declo, Deloris, Finley, Garland, Hatton, Hoff, Longhorn, Manning, Meridian, Promontory, Vona, Wanser, Winridge.

In another embodiment, common wheat (hexaploid, free threshing), Triticum aestivum ssp aestivum includes but is not limited to Sonora, Wit Wolkoring, Chiddam Blanc De Mars, India-Jammu, Foisy.

In still another embodiment, spelt wheat (hexaploid, not free threshing), Triticum aestivum ssp spelta includes but is not limited to Spanish Spelt, Swiss Spelt.

In yet another embodiment, Emmer Wheat (tetraploid), Triticum turgidum ssp. dicoccum includes but is not limited to Ethiopian Blue Tinge.

In another embodiment, pasta wheat (tetraploid, free threshing), Triticum turgidum ssp durum includes but is not limited to Kronos.

In yet another embodiment, Turgidum Wheat (tetraploid, free threshing), Triticum turgidum ssp turgidum includes but is not limited to Akmolinka, Maparcha.

In one embodiment, a cultivar of wheat having at least one Lip1 gene with substantial percent identity to SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 7, and SEQ ID NO: 8 may be used with the methods and compositions disclosed herein.

As used herein with regard to the wheat cultivars, “substantial percent identity” means that the DNA sequence of the gene is sufficiently similar to SEQ ID NO: 1, 2, 4, 5, 7, and 8 at the nucleotide level to code for a substantially similar protein, allowing for allelic differences (or alternate mRNA splicing) between cultivars. In accordance with one embodiment of the invention, “substantial percent identity” may be present when the percent identity in the coding region between the Lip1 gene and SEQ ID NO: 1, 2, 4, 5, 7, and 8 is as low as about 85%, provided that the percent identity in the conserved regions of the gene is higher (e.g., at least about 90%). Preferably the percent identity in the coding region is 85-90%, more preferably 90-95%, and optimally, it is above 95%. Thus, one of skill in the art may prefer to utilize a wheat cultivar having commercial popularity or one having specific desired characteristics in which to create the Lip 1-mutated wheat plants, without deviating from the scope and intent of the present invention. Alternatively, one of skill in the art may prefer to utilize a wheat cultivar having few polymorphisms, such as an in-bred cultivar, in order to facilitate screening for mutations within one or more Lip1 genes in accordance with the present invention.

VI. Representative Methodology for Identification of Lip1 Mutations in a Plant

In order to create and identify the Lip1 mutations and plants disclosed herein, a method known as TILLING (Targeting Induced Local Lesions IN Genomes) was utilized. See McCallum et al., Nature Biotechnology 18:455-457, 2000; McCallum et al., Plant Physiology, 123:439-442, 2000; U.S. Publication No. 20040053236; and U.S. Pat. No. 5,994,075, all of which are incorporated herein by reference. In the basic TILLING methodology, plant materials, such as seeds, are subjected to chemical mutagenesis, which creates a series of mutations within the genomes of the seeds' cells. The mutagenized seeds are grown into adult M1 plants and self-pollinated. DNA samples from the resulting M2 plants are pooled and are then screened for mutations in a gene of interest. Once a mutation is identified in a gene of interest, the seeds of the M2 plant carrying that mutation are grown into adult M3 plants and screened for the phenotypic characteristics associated with the gene of interest.

The hexaploid cultivar Express and tetraploid cultivar Kronos were used. The diploid rice cultivars TR64 and Cypress were used.

In one embodiment, seeds from a plant are mutagenized and then grown into M1 plants. The M1 plants are then allowed to self-pollinate and seeds from the M1 plant are grown into M2 plants, which are then screened for mutations in their Lip1 loci. While M1 plants can be screened for mutations in accordance with alternative embodiments of the invention, one advantage of screening the M2 plants is that all somatic mutations correspond to germline mutations.

One of skill in the art will understand that a variety of plant materials, including, but not limited to, seeds, pollen, plant tissue or plant cells, may be mutagenized in order to create the Lip1-mutated plants disclosed herein. However, the type of plant material mutagenized may affect when the plant DNA is screened for mutations. For example, when pollen is subjected to mutagenesis prior to pollination of a non-mutagenized plant, the seeds resulting from that pollination are grown into M1 plants. Every cell of the M1 plants will contain mutations created in the pollen, thus these M1 plants may then be screened for Lip1 mutations instead of waiting until the M2 generation.

Mutagens that create primarily point mutations and deletions, insertions, transversions, and or transitions, such as chemical mutagens or radiation, may be used to create the mutations. Mutagens conforming with the method of the invention include, but are not limited to, ethyl methanesulfonate (EMS), methylmethane sulfonate (MMS), N-ethyl-N-nitrosourea (ENU), triethylmelamine (TEM), N-methyl-N-nitrosourea (MNU), procarbazine, chlorambucil, cyclophosphamide, diethyl sulfate, acrylamide monomer, melphalan, nitrogen mustard, vincristine, dimethylnitrosamine, N-methyl-N′-nitro-Nitrosoguanidine (MNNG), nitrosoguanidine, 2-aminopurine, 7, 12 dimethyl-benz(a)anthracene (DMBA), ethylene oxide, hexamethylphosphoramide, bisulfan, diepoxyalkanes (diepoxyoctane (DEO), diepoxybutane (BEB), and the like), 2-methoxy-6-chloro-9[3-(ethyl-2-chloro-ethyl)aminopropylamino] acridine dihydrochloride (ICR-170), formaldehyde, fast neutrons, and gamma irradiation. Spontaneous mutations in a Lip1 gene that may not have been directly caused by the mutagen can also be identified.

Other methods such as genome editing can also be used to alter the sequence of a target gene including its promoter to up or down regulate expression or activity. These methods are known to those skilled in the art, and include CRISPR, Talens, Zinc finger nucleases and miRNA among other methods. For example, see a review of these methods by Xiong et al. Horticulture Research 2: 15019, 2015.

Any suitable method of plant DNA preparation now known or hereafter devised may be used to prepare the wheat plant DNA for Lip1 mutation screening. For example, see Chen & Ronald, Plant Molecular Biology Reporter 17:53-57, 1999; Stewart and Via, Bio Techniques 14:748-749, 1993. Additionally, several commercial kits designed for this purpose are available, including kits from Qiagen (Valencia, Calif.) and Qbiogene (Carlsbad, Calif.).

In one embodiment, prepared DNA from individual wheat plants are pooled in order to expedite screening for mutations in one or more Lip1 genes of the entire population of plants originating from the mutagenized plant tissue. The size of the pooled group may be dependent upon the sensitivity of the screening method used. Preferably, groups of two or more individual wheat plants are pooled.

In another embodiment, after the DNA samples are pooled, the pools are subjected to Lip1 sequence-specific amplification techniques, such as Polymerase Chain Reaction (PCR). For a general overview of PCR, see PCR Protocols: A Guide to Methods and Applications (Innis, Gelfand, Sninsky, and White, eds.), Academic Press, San Diego, 1990.

Any primer specific to an Lip1 locus or the sequences immediately adjacent to one of these loci may be utilized to amplify the Lip1 sequences within the pooled DNA sample. Preferably, the primer is designed to amplify the regions of the Lip1 locus where useful mutations are most likely to arise. Most preferably, the primer is designed to detect exonic regions of one or more Lip1 genes. Additionally, it is preferable for the primer to target known polymorphic sites to design genome specific primers in order to ease screening for point mutations in a particular genome.

In one embodiment, wheat tilling primers are designed based upon the Lip1 genes of wheat: Lip-A1, Lip-D1 and Lip-B1 (SEQ ID NOs: 1, 2, 4, 5, 7 and 8). Table 5 shows exemplary primers that have proven useful in identifying mutations in Lip-A1 of wheat (SEQ ID NOs: 10-11), Lip-D1 (SEQ ID NOs: 12-13), Lip-B1 (SEQ ID NOs: 14-15). Also in Table 5 are exemplary primers (SEQ ID NOs: 16-17) that have proven useful as markers to identifying intact versus missing Lip-B1 genomic sequences, and exemplary primers (SEQ ID NOs: 18-25) that have proven useful to evaluate gene expression of multiple wheat lipase genes. These primers are also detailed in the Sequence Listing appended hereto.

In another embodiment, primers are designed based upon the OsLip1 DNA sequences (SEQ ID NOs: 26-27). Table 5 also shows exemplary primers that have proven useful in identifying mutations in OsLip1 (SEQ ID NOs: 29-30).

TABLE 5 Exemplary Primers SEQ ID NO: Ta_Lip1_A_L2 GAAATTGATCTTCTGCAC 10 TTGTGTTCAGGA SEQ ID NO: Ta_Lip1_A_R1 TGGGGATAATGTTAGAAC 11 TAGGAGCTA SEQ ID NO: Ta_Lip1_DB_L1 GACAGGCAAAAATCAATT 12 GGGGTCATTT SEQ ID NO: Ta_Lip1_D_R3 TGATCAGTGGGGAAATGT 13 TAGAATTAGGAGA SEQ ID NO: Ta_Lip1_B_L1 CTGAAATTGATCTTCTGC 14 ACTTGTGTTATTGCA SEQ ID NO: Ta_Lip1_B_R1 AGCATAACACAGCGATAA 15 AGGCTTCCTAGG SEQ ID NO: Ta_Lip1_B_Lmarker TCTCTGTCAAGAATCACG 16 GTC SEQ ID NO: Ta_Lip1_B_Rmarker GCTGCTGCATATGACACC 17 TA SEQ ID NO: Ta_Lip1_L1 CACAGTGGATTTTTCTCC 18 TCCT SEQ ID NO: Ta_Lip1_R1 CCGATATCCCCATATGTC 19 TTTC SEQ ID NO: Ta_Lip2_L1 GACCCAGTTTCAACAGCA 20 AC SEQ ID NO: Ta_Lip2_R1 CGGACCTAACAGCTCTAT 21 ATA SEQ ID NO: Ta_Lip3_L3 CACTTGATCTTGTTGTGA 22 ACTAC SEQ ID NO: Ta_Lip3_R3 GCGTGAGGCAAGTATCTC 23 TT SEQ ID NO: Ta_GAPD_F TGTCCATGCCATGACTGC 24 AA SEQ ID NO: Ta_GAPD_R CCAGTGCTGCTTGGAATG 25 ATG SEQ ID NO: OsLip1_L2 CACCTACTCCGATTGGGC 29 TTAATTTCACA SEQ ID NO: OsLip1_R8 GAACAAGACTGTATCAGT 30 TTACATAACAACCAATG

In another embodiment, the PCR amplification products may be screened for Lip1 mutations using any method that identifies nucleotide differences between wild type and mutant sequences. These may include, for example, without limitation, sequencing, denaturing high pressure liquid chromatography (dHPLC), constant denaturant capillary electrophoresis (CDCE), temperature gradient capillary electrophoresis (TGCE) (see Li et al., Electrophoresis 23(10):1499-1511, 2002), or by fragmentation using enzymatic cleavage, such as used in the high throughput method described by Colbert et al., Plant Physiology 126:480-484, 2001. Preferably, the PCR amplification products are incubated with an endonuclease that preferentially cleaves mismatches in heteroduplexes between wild type and mutant sequences.

In another embodiment, cleavage products are electrophoresed using an automated sequencing gel apparatus, and gel images are analyzed with the aid of a standard commercial image-processing program.

In another embodiment, DNA or RNA from plants with induced or naturally occurring mutations or deletions can be screened with or without PCR by next generation sequencing methods such as exome capture or TILLING by sequencing (King, Robert, et al. Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing. PloS one 10.9 (2015): e0137549; Tsai, Helen, et al. Discovery of rare mutations in populations: TILLING by sequencing. Plant physiology 156.3 (2011): 1257-1268; Liu, Sanzhen, et al. “Gene mapping via bulked segregant RNA-Seq (BSR-Seq).” PLoS One 7.5 (2012): e36406).

In yet another embodiment, once an M2 plant having a mutated Lip1 gene sequence is identified, the mutations are analyzed to determine their effect on the expression, translation, and/or activity of an Lip1 enzyme. In one embodiment, the PCR fragment containing the mutation is sequenced, using standard sequencing techniques, in order to determine the exact location of the mutation in relation to the overall Lip1 sequence. Each mutation is evaluated in order to predict its impact on protein function (i.e., from completely tolerated to causing loss-of-function) using bioinformatics tools such as SIFT (Sorting Intolerant from Tolerant; Ng and Henikoff, Nucleic Acids Research 31:3812-3814, 2003), PSSM (Position-Specific Scoring Matrix; Henikoff and Henikoff, Computer Applications in the Biosciences 12:135-143, 1996) and PARSESNP (Taylor and Greene, Nucleic Acids Research 31:3808-3811, 2003). For example, a SIFT score that is less than 0.05 and a large change in PSSM score (e.g., roughly 10 or above) indicate a mutation that is likely to have a deleterious effect on protein function. These programs are known to be predictive, and it is understood by those skilled in the art that the predicted outcomes are not always accurate.

In another embodiment, if the initial assessment of a mutation in the M2 plant indicates it to be of a useful nature and in a useful position within an Lip1 gene, including its promoter, then further phenotypic analysis of the wheat plant containing that mutation may be pursued. In hexaploid wheat, mutations in each of the A, B and D genomes usually must be combined before a phenotype can be detected. In tetraploid wheat, A and B genome mutations are combined. In addition, the mutation containing plant can be backcrossed or outcrossed two times or more in order to eliminate background mutations at any generation. Then the backcrossed or outcrossed plant can be self-pollinated or crossed in order to create plants that are homozygous for the Lip1 mutations.

Several physical characteristics of these homozygous Lip1 mutant plants are assessed to determine if the mutation results in a useful phenotypic change in the wheat plant without resulting in undesirable negative effects, such as significantly reduced seed yields or issues with germination.

VII. Methods of Producing a Plant

In another embodiment, the disclosure relates to a method for producing a plant having plant products or plant parts with increased hydrolytic and/or oxidative stability. In another embodiment, the disclosure relates to a method for producing a plant having plant products or plant parts with an increased shelf-life.

In one embodiment, the method comprises inducing at least one non-transgenic mutation in at least one copy of an Lip1 gene in plant material or plant parts from a parent plant; growing or using the mutagenized plant material to produce progeny plants; analyzing mutagenized plant material and/or progeny plants to detect at least one mutation in at least one copy of a Lip1 gene; and selecting progeny plants that have at least one mutation in at least one copy of an Lip1 gene.

In another embodiment, the method further comprises crossing progeny plants that have at least one mutation in at least one copy of an Lip1 gene with other progeny plants that have at least one mutation in a different copy of an Lip1 gene. The process of identifying progeny plants with mutations and crossing said progeny plants with other progeny plants, which have mutations, can be repeated to produce progeny plants with reduced Lip1 enzyme activity.

In another embodiment, the disclosure relates to a method of producing a wheat plant comprising out-crossing Lip1 gene mutations in a wheat plant to a wild type wheat.

In another embodiment, the disclosure relates to a method for producing a wheat plant producing grains and flour with increased hydrolytic and oxidative stability and products from grain of said wheat plant having increased shelf life. In still another embodiment, the invention relates to a method for producing a wheat plant having reduced activity of one or more Lip1 enzymes compared to the wild type wheat plants.

In yet another embodiment, the disclosure relates to a method for producing a rice plant producing seeds with increased hydrolytic and oxidative stability and products from seeds of said rice plant having increased shelf life. In still another embodiment, the disclosure relates to a method for producing a rice plant having seeds with reduced activity of one or more Lip1 enzymes compared to the wild type rice plants.

In another embodiment, the activity of the Lip1 protein in a plant is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, or 95-99% of the activity of the Lip1 protein in the wild type plant.

In another embodiment, the activity of the Lip1 protein in grain from a plant is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, or 95-99% of the activity of the Lip1 protein in the wild type grain.

In another embodiment, the activity of the Lip1 protein in seed from a plant is reduced to 0-2%, 2-5%, 5-7%, 7-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 40-45%, 45-50%, 50-60%, 60-70%, 70-80%, 80-90%, 90-95%, or 95-99% of the activity of the Lip1 protein in the wild type seed.

A. Methods of Producing a Wheat Plant with One or More Mutations in the Lip1 Gene in More than One Genome

In still another embodiment, the disclosure relates to a method for producing a wheat plant comprising inducing at least one non-transgenic mutation in at least one copy of a Lip1 gene in plant material from a parent wheat plant that comprises a mutation in a Lip1 gene; growing or using the mutagenized plant material to produce progeny wheat plants; and selecting progeny wheat plants that have at least one mutation in at least one copy of an a Lip1 gene.

In still another embodiment, the disclosure relates to a method for producing a wheat plant comprising inducing at least one non-transgenic mutation in at least one copy of a Lip1 gene in plant material from a parent wheat plant that comprises a mutation in a Lip1 gene; growing or using the mutagenized plant material to produce progeny wheat plants; crossing to plants containing at least one non-transgenic mutation in at least one copy of a Lip 1 gene, and selecting progeny wheat plants that have at least one mutation in at least two copies of an a Lip1 gene.

In yet another embodiment, the disclosure relates to a method for producing a wheat plant comprising inducing at least one non-transgenic mutation in at least one copy of an Lip1 gene in plant material from a parent wheat plant that comprises at least one mutation in two Lip1 genes; growing or using the mutagenized plant material to produce progeny wheat plants; crossing to plants containing at least one non-transgenic mutation in at least one copy of a Lip 1 gene, and selecting progeny wheat plants that have at least one mutation in three copies of an Lip1 gene. In this embodiment, there would be at least one mutation in the Lip1 gene of the A, B and D genomes.

For example, the parent wheat plant may have a mutation in a Lip-A1 gene of the A genome and is crossed to a plant with a mutation in a Lip-D1 gene of the D genome and the selected progeny wheat plants may have a mutation in both the Lip-A1 of the A genome and Lip-D1 gene of the D genome. Alternatively, the parent wheat plant may have a mutation in an Lip-A1 gene of the A genome and is crossed to a plant with a mutation in a Lip-B1 gene of the B genome and the selected progeny wheat plants may have a mutation in both the Lip-A1 of the A genome and Lip-B1 gene of the B genome. Alternatively, the parent wheat plant may have a mutation in an Lip-B1 gene of the B genome and is crossed to a plant with a mutation in a Lip-D1 gene of the D genome and the selected progeny wheat plants may have a mutation in both the Lip-B1 of the B genome and Lip-D1 gene of the D genome. Or the parent wheat plant may have a mutation in an Lip-A1 gene of the A genome and is crossed to a plant with a mutation in a Lip-D1 gene of the D and a plant with a mutation in a Lip-B1 gene of the B genome and the selected progeny wheat plants may have a mutation in the Lip-A1 gene of the A genome, the Lip-B1 gene of the B genome and the Lip-D1 gene of the D genome. These examples are provided merely for clarification and should not limit the methods or gene combinations disclosed herein.

In another embodiment, the disclosure relates to a method for producing a wheat plant comprising crossing a first wheat plant that has at least one non-transgenic mutation in a first Lip1 gene with a second wheat plant that has at least one non-transgenic mutation in a second Lip1 gene; and selecting progeny wheat plants that have at least one mutation in at least two copies of an Lip1 gene. In this embodiment, there would be at least one mutation in the Lip1 gene of the A and D genomes or the A and B genomes or the B and D genomes.

In another embodiment, the disclosure relates to a method for producing a wheat plant comprising crossing a first wheat plant that has at least one non-transgenic mutation in a first and second Lip1 gene with a second wheat plant that has at least one non-transgenic mutation in a third Lip1 gene; and selecting progeny wheat plants that have at least one mutation in all three copies of an Lip1 gene. In this embodiment, there would be at least one mutation in the Lip1 gene of the A, B and D genomes.

VIII. Plants, Seed and Parts of Plant

In one embodiment, a plant is produced according to the methods disclosed herein. In another embodiment, the plant, seed or parts of a plant have one or more mutations in an Lip1 gene. In another embodiment, the plant, seed or parts of a plant have one or more mutations in one or more Lip1 genes.

In another embodiment, the disclosure relates to a plant, seed or parts of a plant comprising one or more non-transgenic mutations in one or more Lip1 genes.

In another embodiment, the disclosure relates to a wheat plant, wheat seed or parts of a wheat plant comprising at least one non-transgenic mutation in the Lip1 gene in each of two genomes. In still another embodiment, the disclosure relates to a wheat plant, wheat seed or parts of a wheat plant comprising at least one non-transgenic mutation in the Lip1 gene in each of three genomes.

In one embodiment, the wheat plant, wheat seed or parts of a wheat plant comprises one or more non-transgenic mutations in both alleles of the Lip1 gene in the A genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip1 gene of the A genome.

In one embodiment, the wheat plant, wheat seed or parts of a wheat plant comprises one or more non-transgenic mutations in both alleles of the Lip1 gene in the B genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip1 gene of the B genome.

In one embodiment, the wheat plant, wheat seed or parts of a wheat plant comprises one or more non-transgenic mutations in both alleles of the Lip1 gene in the D genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip1 gene of the D genome.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 1 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 1.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 1 that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 3.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 1.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 3.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 2 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 4.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 2 that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 6.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 4.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 6.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 3 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 7.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations listed in Table 3 that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 9.

In another embodiment, the wheat plant, wheat seed or parts of the wheat plant comprise a polynucleotide with one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 7.

In still another embodiment, the wheat plant, wheat seed or parts of a wheat plant comprise a polynucleotide with one or more non-transgenic mutations that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 9.

In another embodiment, the wheat plant, wheat seed or parts of a wheat plant has one or more mutations in the Lip1 gene including but not limited to one or more mutations enumerated in Tables 1-3 and corresponding mutations in the homoeologues. A wheat plant, wheat seed or parts of a wheat plant can be generated having 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or greater than 25 of the mutations disclosed herein including but not limited to the mutations disclosed in Tables 1, 2 and 3 as well as mutations in the corresponding homoeologues.

In another embodiment, the wheat seed containing one or more mutations disclosed herein germinates at a rate comparable to wild type wheat seed. In still another embodiment, the wheat seed containing one or more mutations disclosed herein has physical characteristics, including but not limited to size, weight, length, comparable to wild type wheat seed.

In still another embodiment, the wheat plants containing one or more mutations disclosed herein has fertility comparable wild type wheat plants.

In one embodiment, the rice plant, rice seed or parts of a rice plant comprises one or more non-transgenic mutations in both alleles of the OsLip1 gene. In another embodiment, the non-transgenic mutations are identical in both alleles of the OsLip1 gene.

In another embodiment, the rice plant, rice seed or parts of the rice plant comprise a polynucleotide with one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 24.

In still another embodiment, the rice plant, rice seed or parts of the rice plant comprise a polynucleotide with one or more non-transgenic mutations that codes for a OsLip1 protein, wherein the OsLip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 26.

In another embodiment, the wheat plant, wheat seed or parts of a wheat plant has one or more mutations in the Lip1 gene including but not limited to one or more mutations enumerated in Tables 1-3 and corresponding mutations in the homoeologues. A wheat plant, wheat seed or parts of a wheat plant can be generated having 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or greater than 25 of the mutations disclosed herein including but not limited to the mutations disclosed in Tables 1, 2 and 3, as well as mutations in the corresponding homoeologues.

In another embodiment, the rice seed containing one or more mutations disclosed herein germinates at a rate comparable to wild type rice seed. In still another embodiment, the rice seed containing one or more mutations disclosed herein has physical characteristics, including but not limited to size, weight, length, comparable to wild type rice seed.

In still another embodiment, the rice plants containing one or more mutations disclosed herein has fertility comparable wild type rice plants.

IX. Grain, Flour, Starch and Seeds

In another embodiment, the disclosure relates to a grain, flour, starch or bran comprising one or more non-transgenic mutations in the Lip1 gene. In another embodiment, the disclosure relates to grain comprising an embryo, wherein the embryo comprises one or more non-transgenic mutations in a Lip1 gene.

In another embodiment, the grain, flour, bran, or starch comprises one or more non-transgenic mutations in the Lip1 genes including but not limited to the mutations recited in Tables 1-3 for wheat and Table 4 for rice and the corresponding mutations in homoeologues. In still another embodiment, the disclosure relates to grain or flour comprising at least one non-transgenic mutation in the Lip1 gene in one, two or three genomes.

In still another embodiment, the disclosure relates to a wheat grain, flour or starch comprising one or more non-transgenic mutations in the Lip-A1 gene. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip-A1 gene of the A genome.

In one embodiment, the wheat grain, flour or starch comprises one or more non-transgenic mutations in both alleles of the Lip-D1 gene in the D genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip-D1 gene of the D genome.

In one embodiment, the wheat grain, flour or starch comprises one or more non-transgenic mutations in both alleles of the Lip-B1 gene in the B genome. In another embodiment, the non-transgenic mutations are identical in both alleles of the Lip-B1 gene of the B genome.

In one embodiment, the disclosure relates to wheat grain, wheat flour or starch comprising a polynucleotide of the Lip-A1 gene in the A genome with one or more non-transgenic mutations listed in Table 1 and corresponding to SEQ ID NO: 1. In another embodiment, the wheat grain or wheat flour comprise a polynucleotide with one or more non-transgenic mutations listed in Table 1 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 1.

In still another embodiment, wheat grain, wheat flour or starch comprise a polynucleotide with one or more non-transgenic mutations listed in Table 1 that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 3.

In one embodiment, the disclosure relates to wheat grain, wheat flour or starch comprising a polynucleotide of the Lip-D1 gene in the D genome with one or more non-transgenic mutations listed in Table 2 and corresponding to SEQ ID NO: 4. In another embodiment, the wheat grain or wheat flour comprise a polynucleotide with one or more non-transgenic mutations listed in Table 2 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 4.

In still another embodiment, wheat grain, wheat flour or starch comprise a polynucleotide with one or more non-transgenic mutations listed in Table 2 that codes for a Lip-D1 protein, wherein the Lip-D1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 6.

In one embodiment, the disclosure relates to wheat grain, wheat flour or starch comprising a polynucleotide of the Lip-B1 gene in the B genome with one or more non-transgenic mutations listed in Table 3 and corresponding to SEQ ID NO: 7. In another embodiment, the wheat grain or wheat flour comprise a polynucleotide with one or more non-transgenic mutations listed in Table 3 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 7.

In still another embodiment, wheat grain, wheat flour or starch comprise a polynucleotide with one or more non-transgenic mutations listed in Table 3 that codes for a Lip-B1 protein, wherein the Lip-B1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 9.

In still another embodiment, the disclosure relates to wheat grain or flour comprising an endosperm and a reduced gene expression level, activity or expression level and activity of the Lip1 gene as compared to wild type wheat grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip1 gene exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip1 gene exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-A1 gene exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-A1 gene exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-D1 gene exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-D1 gene exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-B1 gene exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-B1 gene exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-A1 and Lip-D1 genes exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-A1 and Lip-D1 genes exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-A1 and Lip-B1 genes exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-A1 and Lip-B1 genes exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-B1 and Lip-D1 genes exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-B1 and Lip-D1 genes exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In yet another embodiment, the disclosure relates to wheat grain or flour with one or more mutations in the Lip-A1, Lip-B1 and Lip-D1 genes exhibiting increased shelf life as compared to wild type wheat grain or flour. In another embodiment, wheat grain or flour with one or more mutations in the Lip-A1, Lip-B1 and Lip-D1 genes exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain or flour.

In still another embodiment, the disclosure relates to rice grain comprising one or more non-transgenic mutations in the OsLip1 gene. In another embodiment, the non-transgenic mutations are identical in both alleles of the OsLip1 gene.

In one embodiment, the disclosure relates to rice grain comprising a polynucleotide of the OsLip1 gene with one or more non-transgenic mutations listed in Table 4 and corresponding to SEQ ID NO: 26. In another embodiment, the rice grain comprises a polynucleotide with one or more non-transgenic mutations listed in Table 4 and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 26.

In still another embodiment, rice grain comprise a polynucleotide with one or more non-transgenic mutations listed in Table 4 that codes for a Lip1 protein, wherein the Lip1 protein comprises one or more non-transgenic mutations and is 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or greater than 99% identical or similar to SEQ ID NO: 28.

In yet another embodiment, the disclosure relates to rice grain with one or more mutations in the OsLip1 gene exhibiting increased shelf life as compared to wild type rice grain.

In another embodiment, rice grain with one or more mutations in the Lip1 gene exhibits from 0-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 90-95%, and greater than 95% increased shelf life as compared to wild type grain.

X. Food Products

In one embodiment, the disclosure is directed to a flour or other product produced from the grain or flour discussed above. In another embodiments, the flour, the coarse fraction or purified starch may be a component of a food product. In one embodiment, a food product is produced from wheat grain disclosed herein. In still another embodiment, a food product is produced from rice grain disclosed herein.

The food product includes but is not limited to a bagel, a biscuit, a bread, a bun, a croissant, a dumpling, an English muffin, a muffin, a pita bread, a quickbread, a refrigerated/frozen dough products, dough, baked beans, a burrito, chili, a taco, a tamale, a tortilla, a pot pie, a ready to eat cereal, a ready to eat meal, stuffing, a microwaveable meal, a brownie, a cake, a cheesecake, a coffee cake, a cookie, a dessert, a pastry, a sweet roll, a candy bar, a pie crust, pie filling, baby food, a baking mix, a batter, a breading, a gravy mix, a meat extender, a meat substitute, a seasoning mix, a soup mix, a gravy, a roux, a salad dressing, a soup, sour cream, a noodle, a pasta, ramen noodles, chow mein noodles, lo mein noodles, an ice cream inclusion, an ice cream bar, an ice cream cone, an ice cream sandwich, a cracker, a crouton, a doughnut, an egg roll, an extruded snack, a fruit and grain bar, a microwaveable snack product, a nutritional bar, a pancake, a par-baked bakery product, a pretzel, a pudding, a granola-based product, a snack chip, a snack food, a snack mix, a waffle, a pizza crust, animal food or pet food.

In one embodiment, the flour is a whole grain flour (ex.—an ultrafine-milled whole grain flour, such as an ultrafine-milled whole grain wheat flour). In one embodiment, the whole grain flour includes a refined flour constituent (ex.—refined wheat flour or refined flour) and a coarse fraction (ex.—an ultrafine-milled coarse fraction). Refined wheat flour may be flour which is prepared, for example, by grinding and bolting (sifting) cleaned wheat. The Food and Drug Administration (FDA) requires flour to meet certain particle size standards in order to be included in the category of refined wheat flour. The particle size of refined wheat flour is described as flour in which not less than 98% passes through a cloth having openings not larger than those of woven wire cloth designated “212 micrometers (U.S. Wire 70).”

In another embodiment, the coarse fraction includes at least one of: bran and germ. For instance, the germ is an embryonic plant found within the wheat kernel. The germ includes lipids, fiber, vitamins, protein, minerals and phytonutrients, such as flavonoids. The bran may include several cell layers and has a significant amount of lipids, fiber, vitamins, protein, minerals and phytonutrients, such as flavonoids.

For example, the coarse fraction or whole grain flour or refined flour of the present invention may be used in various amounts to replace refined or whole grain flour in baked goods, snack products, and food products. The whole grain flour (i.e.—ultrafine-milled whole grain flour) may also be marketed directly to consumers for use in their homemade baked products. In an exemplary embodiment, a granulation profile of the whole grain flour is such that 98% of particles by weight of the whole grain flour are less than 212 micrometers.

In another embodiment, the whole grain flour or coarse fraction or refined flour may be a component of a nutritional supplement. The nutritional supplement may be a product that is added to the diet containing one or more ingredients, typically including: vitamins, minerals, herbs, amino acids, enzymes, antioxidants, herbs, spices, probiotics, extracts, prebiotics and fiber.

In a further embodiment, the nutritional supplement may include any known nutritional ingredients that will aid in the overall health of an individual, examples include but are not limited to carotenoids, vitamins, minerals, other fiber components, fatty acids, antioxidants, amino acids, peptides, proteins, lutein, ribose, omega-3 fatty acids, and/or other nutritional ingredients. Because of the high nutritional content of the endosperm of the present invention, there may be many uses that confer numerous benefits to an individual, including, delivery of fiber and other essential nutrients, increased digestive function and health, weight management, blood sugar management, heart health, diabetes risk reduction, potential arthritis risk reduction, and overall health and wellness for an individual.

In still another embodiments, the whole grain flour or coarse fraction or refined flour may be a component of a dietary supplement. The Code of Federal Regulations defines a dietary supplement as a product that is intended to supplement the diet and contains one or more dietary ingredients including: vitamins, minerals, herbs, botanicals, amino acids, and other substances or their constituents; is intended to be taken by mouth as a pill, capsule, tablet, or liquid; and is labeled on the front panel as being a dietary supplement.

In yet another embodiment, the whole grain flour or coarse fraction or refined flour may be a fiber supplement or a component thereof. The fiber supplement may be delivered in, but is not limited to the following forms: instant beverage mixes, ready-to-drink beverages, nutritional bars, wafers, cookies, crackers, gel shots, capsules, chews, chewable tablets, and pills. One embodiment delivers the fiber supplement in the form of a flavored shake or malt type beverage.

In another embodiment, the whole grain flour or coarse fraction or refined flour may be included as a component of a digestive supplement. The whole grain flour or coarse fraction or refined flour may be a component of a digestive supplement alone or in combination with one or more prebiotic compounds and/or probiotic organisms. Prebiotic compounds are non-digestible food ingredients that may beneficially affect the host by selectively stimulating the growth and/or the activity of a limited number of microorganisms in the colon. Examples of prebiotic compounds within the scope of the invention, may include, but are not limited to: oligosaccharides and inulins.

Probiotics are microorganisms which, when administered in adequate amounts, confer a health benefit on the host. Probiotic organisms include, but are not limited to: Lactobacillus, Bifidobacteria, Escherichia, Clostridium, Lactococcus, Streptococcus, Enterococcus, and Saccharomyces.

In yet another embodiment, the whole grain flour or coarse fraction or refined flour may be included as a component of a functional food. The Institute of Food Technologists defines functional foods as, foods and food components that provide a health benefit beyond basic nutrition. This includes conventional foods, fortified, enriched, or enhanced foods, and dietary supplements. The whole grain flour and coarse fraction or refined flour include numerous vitamins and minerals, have high oxygen radical absorption capacities, and are high in fiber, making them ideally suited for use in/as a functional food.

In another embodiment, the whole grain flour or coarse fraction or refined flour may be used in medical foods. Medical food is defined as a food that is formulated to be consumed or administered entirely under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. The nutrient contents and antioxidant capacities of the whole grain flour and coarse fraction or refined flour make them ideal for use in medical foods.

In yet another embodiment, the whole grain flour or coarse fraction or refined flour may also be used in pharmaceuticals. The whole grain flour and coarse fraction or refined flour are high in fiber and have a very fine granulation making them suitable for use as a carrier in pharmaceuticals.

In still another embodiment, delivery of the whole grain flour or coarse fraction or refined flour as a nutritional supplement, dietary supplement or digestive supplement is contemplated via delivery mechanisms where the whole grain flour or coarse fraction is the single ingredient or one of many nutritional ingredients. Examples of delivery mechanisms include but are not limited to: instant beverage mixes, ready-to-drink beverages, nutritional bars, wafers, cookies, crackers, gel shots, capsules, and chews.

In yet another embodiment, a milling process may be used to make a multi-wheat flour, or a multi-grain coarse fraction. In one embodiment, bran and germ from one type of wheat may be ground and blended with ground endosperm or whole grain wheat flour of another type of wheat. Alternatively bran and germ of one type of grain may be ground and blended with ground endosperm or whole grain flour of another type of grain.

In still another embodiment, bran and germ from a first type of wheat or grain may be blended with bran and germ from a second type of wheat or grain to produce a multi-grain coarse fraction. It is contemplated that the invention encompasses mixing any combination of one or more of bran, germ, endosperm, and whole grain flour of one or more grains. This multi-grain, multi-wheat approach may be used to make custom flour and capitalize on the qualities and nutritional contents of multiple types of grains or wheats to make one flour.

The whole grain flour of the invention may be produced via a variety of milling processes. One exemplary process involves grinding grain in a single stream without separating endosperm, bran, and germ of the grain into separate streams. Clean and tempered grain is conveyed to a first passage grinder, such as a hammermill, roller mill, pin mill, impact mill, disc mill, air attrition mill, gap mill, or the like.

After grinding, the grain is discharged and conveyed to a sifter. Any sifter known in the art for sifting a ground particle may be used. Material passing through the screen of the sifter is the whole grain flour of the invention and requires no further processing. Material that remains on the screen is referred to as a second fraction. The second fraction requires additional particle reduction. Thus, this second fraction may be conveyed to a second passage grinder.

After grinding, the second fraction may be conveyed to a second sifter. Material passing through the screen of the second sifter is the whole grain flour. The material that remains on the screen is referred to as the fourth fraction and requires further processing to reduce the particle size. The fourth fraction on the screen of the second sifter is conveyed back into either the first passage grinder or the second passage grinder for further processing via a feedback loop.

It is contemplated that the whole grain flour, coarse fraction, purified starch and/or grain products of the disclosure may be produced by a number of milling processes known in the art.

In another embodiment, the bran fraction is from rice and products are derived from it such as rice bran oil.

XI. Plant Breeding

In another embodiment, the disclosure is directed to methods for plant breeding using wheat plants and plant parts with one or more non-transgenic mutations in the Lip1 genes.

One such embodiment is the method of crossing wheat variety with one or more non-transgenic mutations in the Lip1 genes with another variety of wheat to form a first generation population of F1 plants. The population of first generation F1 plants produced by this method is also an embodiment of the invention. This first generation population of F1 plants will comprise an essentially complete set of the alleles of wheat variety with one or more non-transgenic mutations in the Lip1 genes. One of ordinary skill in the art can utilize either breeder books or molecular methods to identify a particular F1 plant produced using wheat variety with one or more non-transgenic mutations in the Lip1 genes, and any such individual plant is also encompassed by this invention. These embodiments also cover use of transgenic or backcross conversions of wheat varieties with one or more mutations in the Lip1 genes to produce first generation F1 plants.

In another embodiment, the invention relates to a method of developing a progeny wheat plant. A method of developing a progeny wheat plant comprises crossing a wheat variety with one or more non-transgenic mutations in the Lip1 genes with a second wheat plant and performing a breeding method. A specific method for producing a line derived from wheat variety with one or more non-transgenic mutations in the Lip1 genes is as follows.

One of ordinary skill in the art would cross wheat variety with one or more non-transgenic mutations in the Lip1 gene or genes with another variety of wheat, such as an elite variety. The F1 seed derived from this cross would be grown to form a homogeneous population. The F1 seed would contain one set of the alleles from wheat variety with one or more non-transgenic mutations in the Lip1 gene and one set of the alleles from the other wheat variety.

The F1 genome would be made-up of 50% wheat variety with one or more non-transgenic mutations in the Lip1 gene and 50% of the other elite variety. The F1 seed would be grown to form F2 seed. The F1 seed could be allowed to self, or bred with another wheat cultivar.

On average the F2 seed would have derived 50% of its alleles from wheat variety with one or more non-transgenic mutations in the Lip1 gene and 50% from the other wheat variety, but various individual plants from the population would have a much greater percentage of their alleles derived from wheat variety with one or more non-transgenic mutations in the Lip1 gene (Wang J. and R. Bernardo, 2000, Crop Sci. 40:659-665 and Bernardo, R. and A. L. Kahler, 2001, Theor. Appl. Genet. 102:986-992).

The F2 seed would be grown and selection of plants would be made based on visual observation and/or measurement of traits and/or marker assisted selection. The wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived progeny that exhibit one or more of the desired wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived traits would be selected and each plant would be harvested separately. This F3 seed from each plant would be grown in individual rows and allowed to self. Then selected rows or plants from the rows would be harvested and threshed individually. The selections would again be based on visual observation and/or measurements for desirable traits of the plants, such as one or more of the desirable wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived traits.

The process of growing and selection would be repeated any number of times until a homozygous wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived wheat plant is obtained. The homozygous wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived wheat plant would contain desirable traits derived from wheat variety with one or more non-transgenic mutations in the Lip genes, some of which may not have been expressed by the other original wheat variety to which wheat variety with one or more non-transgenic mutations in the Lip1 gene was crossed and some of which may have been expressed by both wheat varieties but now would be at a level equal to or greater than the level expressed in wheat variety with one or more non-transgenic mutations in the Lip1 gene or genes.

The breeding process, of crossing, selfing, and selection may be repeated to produce another population of wheat variety with one or more non-transgenic mutations in the Lip1 gene-derived wheat plants with, on average, 25% of their genes derived from wheat variety with one or more non-transgenic mutations in the Lip1 gene, but various individual plants from the population would have a much greater percentage of their alleles derived from wheat variety with one or more non-transgenic mutations in the Lip1 gene or genes. Another embodiment of the invention is a homozygous wheat variety with one or more non-transgenic mutations in the Lip gene-derived wheat plant that has received wheat variety with one or more non-transgenic mutations in the Lip gene-derived traits. This breeding process can be repeated as many times as desired.

The disclosure is further described by the following paragraphs:

-   -   1. A plant comprising one or more mutations in the Lip1 gene,         wherein said one or more mutations contributes to a product from         said plant having a characteristic selected from the group         consisting of: (a) increased shelf life; (b) reduced TAG to FFA         production; (c) increased oxidative stability; (d) increased         hydrolytic stability; (e) reduced hexanal production; and (f)         improved sensory characteristics.     -   2. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to milled grain from said wheat plant         having increased shelf-life compared to milled grain from a wild         type wheat plant.     -   3. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to reduced TAG to FFA production in         flour from grain of said plant as compared to flour from grain         of a wild type wheat plant.     -   4. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to increased hydrolytic stability of         products produced from said plant as compared to products         produced from a wild type wheat plant.     -   5. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to increased oxidative stability of         products produced from said plant as compared to products         produced from a wild type wheat plant.     -   6. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to reduced hexanal production in flour         from grain of said plant as compared to flour from grain of a         wild type wheat plant.     -   7. A wheat plant comprising a mutation in the Lip1 gene, wherein         said mutation contributes to products from said wheat plant         having improved sensory aspects as compared to sensory aspects         of products from a wild type wheat plant.     -   8. The wheat plant of any of the preceding paragraphs, further         comprising one or more mutations in at least two genomes.     -   9. The wheat plant of any of the preceding paragraphs comprising         one or more mutations in the A and B genomes.     -   10. The wheat plant of any of the preceding paragraphs         comprising one or more mutations in the A and D genomes.     -   11. The wheat plant of any of the preceding paragraphs, further         comprising one or more mutations in the A, B, and D genomes.     -   12. A wheat plant comprising one or more mutations in the Lip1         gene in the A genome, wherein said mutation contributes to         products from said wheat plant having increased shelf-life         compared to products from a wild type wheat plant.     -   13. A wheat plant comprising one or more mutations in the Lip1         gene in the A genome, wherein said mutation contributes to         reduced TAG to FFA production from stored grain from said plant         as compared to stored grain from a wild type wheat plant.     -   14. The wheat plant of any of the preceding paragraphs, wherein         the Lip1 gene is Lip-A1.     -   15. The wheat plant of any of the preceding paragraphs, further         comprising a mutation in the Lip1 gene of the D genome.     -   16. A wheat plant comprising one or more mutations in the Lip1         gene in the D genome, wherein said mutation contributes to         products from said wheat plant having increased shelf-life         compared to products from a wild type wheat plant.     -   17. A wheat plant comprising one or more mutations in the Lip1         gene in the D genome, wherein said mutation contributes to         reduced TAG to FFA production in grain from said plant as         compared to stored grain from a wild type wheat plant.     -   18. The wheat plant of any of the preceding paragraphs, wherein         the Lip1 gene is Lip-D1.     -   19. The wheat plant of any of the preceding paragraphs further         comprising two or more mutations in the Lip1 gene, wherein the         mutations in the Lip1 gene are on at least two different         genomes.     -   20. The wheat plant of any of the preceding paragraphs, further         comprising a reduced level of Lip1 protein, relative to a         wild-type wheat plant.     -   21. The wheat plant of any of the preceding paragraphs, further         comprising reduced Lip1 enzyme activity relative to a wild-type         wheat plant.     -   22. The wheat plant of any of the preceding paragraphs where the         wheat plant is homozygous for the mutation.     -   23. The wheat plant of any of the preceding paragraphs, wherein         products from said wheat plant have increased hydrolytic         stability as compared to products from a wild type wheat plant.     -   24. The wheat plant of any of the preceding paragraphs, wherein         products from said wheat plant have increased oxidative         stability as compared to products from a wild type wheat plant.     -   25. The wheat plant of any of the preceding paragraphs, which is         Triticum aestivum ssp. aestivum.     -   26. The wheat plant of any of the preceding paragraphs, which is         Triticum durum or Triticum turgidum subsp. Durum.     -   27. The wheat plant of any of the preceding paragraphs, wherein         the one or more mutations in the Lip1 gene is recited in any one         of Tables 1-3.     -   28. The wheat plant of any of the preceding paragraphs, wherein         the one or more mutations in the Lip1 gene results in an amino         acid change recited in Tables 1-3 in the Lip1 protein.     -   29. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to rice seeds or bran         from said rice plant having increased shelf-life compared to         rice seeds or bran from a wild type rice plant.     -   30. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to reduced TAG to FFA         production rice seeds or bran from said rice plant as compared         to rice seeds or bran of a wild type rice plant.     -   31. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to increased hydrolytic         stability of products produced from said rice plant as compared         to products produced from a wild type rice plant.     -   32. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to increased oxidative         stability of products produced from said plant as compared to         products produced from a wild type rice plant.     -   33. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to reduced hexanal         production in rice seeds or bran of said plant as compared to         rice seeds or bran from a wild type rice plant.     -   34. A rice plant comprising one or more mutations in the OsLip1         gene, wherein said mutation contributes to products from said         rice plant having improved sensory aspects as compared to         sensory aspects of products from a wild type rice plant.     -   35. The rice plant of any of the preceding paragraphs, wherein         the one or more mutations in the OsLip1 gene is recited in Table         4.     -   36. The rice plant of any of the preceding paragraphs, further         comprising a reduced level of OsLip1 protein, relative to a         wild-type rice plant.     -   37. The rice plant of any of the preceding paragraphs, further         comprising reduced OsLip1 enzyme activity relative to a         wild-type rice plant.     -   38. The rice plant of any of the preceding paragraphs where the         rice plant is homozygous for the mutation.     -   39. Grain or seed from the plant of any of the preceding         paragraphs, wherein the production of decomposition products of         triacylglycerides is decreased in grain or seed made from said         plant as compared to wild type grain or seed.     -   40. Grain or seed from the plant of any of the preceding         paragraphs, wherein the production of decomposition products of         triacylglycerides is decreased in grain or seed by at least 5%,         or at least 10%, or at least 15%, or at least 20%, or at least         25%, or at least 30%, or at least 35%, or at least 40%, or at         least 45%, or at least 50%, or at least 55%, or at least 60%, or         at least 65%, or at least 70%, or at least 75%, or at least 80%,         or at least 85%, or at least 90%, or at least 95% as compared to         grain or seed from a wild type plant.     -   41. Grain or seed from the plant of any of the preceding         paragraphs, wherein the production of hexanal, or         trans-2-nonenal, or trihydroxydecanoic acid or combinations         thereof is decreased in grain or seed by at least 5%, or at         least 10%, or at least 15%, or at least 20%, or at least 25%, or         at least 30%, or at least 35%, or at least 40%, or at least 45%,         or at least 50%, or at least 55%, or at least 60%, or at least         65%, or at least 70%, or at least 75%, or at least 80%, or at         least 85%, or at least 90%, or at least 95% as compared to grain         or seed from a wild type plant.     -   42. Grain from the plant of any of the preceding paragraphs,         wherein shelf life of whole grain flour made from wheat grain is         increased by 1 month, 2 months, 3 months, 4 months, 5 months, 6         months, 7 months, 8 months, 9 months, 10 months, 11 months, 12         months, 13 months, 14 months, 15 months, 16 months, 17 months,         18 months, 19 months, 20 months, 21 months, 22 months, 23         months, 24 months, 25 months, 26 months, 27 months, 28 months,         29 months, 30 months, or greater than 30 months as compared to         the shelf life of grain or seed made from wild-type grain.     -   43. Grain comprising a mutation in an Lip1 gene, wherein said         mutation contributes to reduced free fatty acid production in         whole grain flour from said grain as compared to grain from a         wild type wheat plant.     -   44. Grain comprising a mutation in an Lip1 gene, wherein said         mutation contributes to increased shelf-life in whole grain         flour from said grain as compared to grain from a wild type         wheat plant.     -   45. Grain comprising a mutation in an Lip1 gene, wherein said         mutation contributes to increased shelf-life in whole grain         flour stored at a higher temperature as compared to grain from a         wild type wheat plant.     -   46. Grain from the plant of any of the preceding paragraphs,         wherein shelf life of whole grain flour made from wheat grain is         improved as determined by sensory characteristics including         color, flavor, texture, aroma, performance or overall preference         of the finished product.     -   47. Rice seed or bran comprising a mutation in an OsLip1 gene,         wherein said mutation contributes to reduced free fatty acid         production in rice seed or bran from a rice plant as compared to         rice seed or bran from a wild type rice plant.     -   48. Rice seed or bran comprising a mutation in an OsLip1 gene,         wherein said mutation contributes to increased shelf-life in         rice seed or bran from said rice plant as compared to rice seed         or bran from a wild type rice plant.     -   49. Rice seed or bran comprising a mutation in an OsLip1 gene,         wherein said mutation contributes to increased shelf-life in         rice seed or bran stored at a higher temperature as compared to         rice seed or bran from a wild type rice plant.     -   50. Rice seed or bran from the plant of any of the preceding         paragraphs, wherein shelf life of rice seed or bran is improved         as determined by sensory characteristics including color,         flavor, texture, aroma, performance or overall preference of the         finished product.     -   51. Rice seed or bran from the rice plant of any of the         preceding paragraphs, wherein shelf life of rice seed or bran         from said rice plant is increased by 1 month, 2 months, 3         months, 4 months, 5 months, 6 months, 7 months, 8 months, 9         months, 10 months, 11 months, 12 months, 13 months, 14 months,         15 months, 16 months, 17 months, 18 months, 19 months, 20         months, 21 months, 22 months, 23 months, 24 months, 25 months,         26 months, 27 months, 28 months, 29 months, 30 months, or         greater than 30 months as compared to the rice seed or bran from         a wild-type plant.     -   52. Wheat grain from a wheat plant of any of the preceding         paragraphs.     -   53. Flour comprising wheat grain of any of the preceding         paragraphs.     -   54. A food product comprising a component of a wheat plant of         any of the preceding paragraphs.     -   55. A wheat seed, plant part or progeny thereof from a wheat         plant of any of the preceding paragraphs.     -   56. A wheat plant substantially as shown and described herein.     -   57. Grain substantially as shown and described herein.     -   58. Wheat seed, plant part or progeny thereof from a wheat plant         substantially as shown and described herein.     -   59. Rice seed or bran from a rice plant of any of the preceding         paragraphs.     -   60. A food product comprising a component of a rice plant of any         of the preceding paragraphs.     -   61. A rice seed, plant part or progeny thereof from a rice plant         of any of the preceding paragraphs.     -   62. A rice plant substantially as shown and described herein.     -   63. Rice seed and rice bran substantially as shown and described         herein.     -   64. Rice seed, plant part or progeny thereof from a rice plant         substantially as shown and described herein.

Example 1

This example describes the identification of novel alleles of Lip1.

A. Identification of Wheat and Rice Lipase 1 Genes

Multiple wheat lipase gene sequences were identified by homology to rice bran lipase II protein sequence (LOC_Os07g47250) using tblastn algoritm on public wheat genome databases. An alignment of the most similar identified translated wheat protein sequences is shown in FIG. 1. In order to assess gene expression for each of the wheat Lipase gene families Lip1, 2 and 3, reverse transcription PCR (RT-PCR) was used Freeman WM, Walker SJ, Vrana KE (January 1999). “Quantitative RT-PCR: pitfalls and potential”. BioTechniques 26 (1): 112-22, 124-5. Total RNA was extracted from leaves from one week old plants, leaves from 4 weeks old plants, developing grains at 6 days post anthesis (DPA), developing grain at 18 DPA, mature grains, roots from 1 week old plants, and stems from 1 week old plants. Tissue was ground in liquid nitrogen and extracted using Qiagen RNeasy plant kit following manufacturer's instructions. For developing and mature seed, total RNA was extracted from frozen ground tissue using 1 mL solution containing 50 mM Tris-HCl (pH 9.0), 200 mM NaCl, 1% sarcosyl, 20 mM EDTA, and 5 mM DTT (Sigma-Aldrich. St. Louis, Mo.) as described by Verlotta et al BMC Plant Biology 10:263 (2010). After incubation for 5 minutes at room temperature, RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, Calif.) followed by Qiagen RNeasy plant kit with buffer RLT following manufacturer instructions. Extracted RNA was treated in solution with DNAse I with a modified manufacturer's protocol using 3.5 μl of DNase per sample at a total incubation time of 30 minutes at room temperature (RNase free DNAse Kit, Qiagen, Valencia, Calif.) and then purified on RNeasy columns. Total RNA concentration and purity was quantified on a Nanodrop 2000c spectrophotometer (ThermoFisher Scientific, Grand Island, N.Y.). 168 ng of Total RNA was used to evaluate genomic contamination and quality using an AdvanCE FS96 Fragment Analyzer (Advanced Analytical, Ames, Iowa). Lack of genomic contamination of RNA was confirmed by PCR and sequencing.

A total of 0.5 μg RNA was reverse transcribed using SuperScript III First-Strand Synthesis SuperMix following the manufacturer instructions (Invitrogen, Carlsbad, Calif.). cDNA were diluted 1:250, and 5 μl was used as a template for PCR in a 201 volume. Each reaction consisted of 1× Ex-Taq Buffer (Takara Biotechnology, Mountain View, Calif.), 0.125 mM dNTPs (Takara Biotechnology, Mountain View, Calif.), 0.125 μM each forward and reverse primers, and 0.83 U Ex-Taq Polymerase (Takara Biotechnology, Mountain View, Calif.). Primers for Glyceraldehyde 3-phosphate dehydrogenase (GAPD) were used as a control. (Jarosova et al. BMC Plant Biology 10 146 (2010)). PCR primers for Lip1 (SEQ ID NOs:18-19) Lip 2 (SEQ ID NOs:20-21) Lip3 (SEQ ID NOs: 22-23) and GAPD (SEQ ID NOs: 24-25) were used to evaluate gene expression as shown in FIG. 2. PCR conditions were 95° C. for 2 minutes, 30 cycles of 95° C. for 30 seconds, 60° C. for 30 seconds and 72° C. for 30 seconds followed by a final extension at 72° C. for 5 minutes. PCR products were separated on 1.1% agarose gels, and documented with a Bio-Rad Gel Imaging System (Bio-Rad, Hercules, Calif., USA).

Lip-B1 sequences were identified in the public databases for hexaploid wheat variety, Chinese Spring. However, PCR amplification of hexaploid wheat variety Express and other varieties indicated that all or part of this gene was missing in some hexaploid wheat varieties. Lip-B1 marker primers (SEQ ID NOs: 16-17) are exemplary primers that have proven useful as a marker to identify wheat varieties containing or lacking some or all of Lip-B1 genomic sequences (FIG. 3). Durum wheat variety Kronos had Lip-B1 sequence in the genome and mutation alleles were identified in that gene (Table 3).

B. Mutagenesis

In accordance with one exemplary embodiment of the present invention, wheat seeds of the hexaploid cultivar (Triticum aestivum) Express were vacuum infiltrated in H₂O (approximately 1,000 seeds/100 ml H₂O for approximately 4 minutes). The seeds were then placed on a shaker (45 rpm) in a fume hood at room temperature. The mutagen ethyl methanesulfonate (EMS) was added to the imbibing seeds to final concentrations ranging from about 0.75% to about 1.2% (v/v). Following an 18-hour incubation period, the EMS solution was replaced 4 times with fresh H₂O.

Rice seeds of the cultivar (Oryza sativa) IR64 or Cypress were vacuum infiltrated in H₂O (approximately 1,000 seeds/100 ml H₂O for approximately 4 minutes). The seeds were then placed on a shaker (45 rpm) in a fume hood at room temperature. The mutagen N-ethyl-N-nitrosourea (ENU) was added to the imbibing seeds to final concentrations from about 0.2, 0.3 or 0.5% for 5.5, 6 or 7 hours. In some cases a combination of EMS (0.2M) and ENU (0.15M) was used.

The seeds were then rinsed under running water for about 4-8 hours. Finally, the mutagenized seeds were planted (96/tray) in potting soil and allowed to germinate indoors. Plants that were four to six weeks old were transferred to the field to grow to fully mature M1 plants. The mature M1 plants were allowed to self-pollinate and then seeds from the M1 plant were collected and planted to produce M2 plants.

C. DNA Preparation

DNA from the M2 plants produced in accordance with the above description was extracted and prepared in order to identify which M2 plants carried a mutation at one or more of their Lip1 loci. The M2 plant DNA was prepared using methods and reagents based on the Qiagen® (Valencia, Calif.) DNeasy® 96 Plant Kit. Approximately 50 mg of frozen plant sample was placed in each sample tube with a stainless steel bead, frozen in liquid nitrogen and ground 2 times for 45 seconds each at 21.5 Hz using the Retsch® Mixer Mill MM 300. Next, 300 μl of solution AP1 [Buffer AP1, solution DX and RNAse (100 mg/ml)] at 80° C. was added to each sample. The tubes were sealed and shaken for 15 seconds, then briefly centrifuged at 5,200×g. Following the addition of 100 μl Buffer P3, the tubes were shaken for 15 seconds. The samples were placed in a freezer at −20° C. for at least 20 min. The samples were then centrifuged for 20 minutes at 5,200×g. A filter plate was placed on the vacuum unit of Tecan Evo liquid handling robot and 400 μl of Buffer AW1 was added to each well. Following the addition of a 300 μl aliquot of supernatant to each well, vacuum was applied until dryness. Next, 650 μl of Buffer AW2 was added to each well of the filter plate. The filter plate was placed on a square well block and centrifuged for 20 minutes at 5,200×g. The filter plate was then placed on a new set of sample tubes and 90 μl of Buffer AE was applied to the filter. It was incubated at room temperature for 1 minute and then spun for 2 minutes at 5,200×g. This step was repeated with an additional 90 μl Buffer AE. The filter plate was removed and the tubes containing the pooled filtrates were capped. The individual samples were then normalized to a DNA concentration of 5 to 10 ng/μl for TILLING, or left un-normalized for genotyping applications.

D. Tilling

The M2 wheat DNA was pooled into groups of two individual plants. The DNA concentration for each individual within the pool was approximately 2 ng/μl with a final concentration of 4 ng/μl for the entire pool. The M2 rice DNA was pooled into groups of six individual plants. The DNA concentration for each individual within the pool was approximately 0.083 ng/μl or 0.17 ng/μl with a final concentration of 0.5 ng/μl or 1 ng/μl for the entire pool. Then, 5 μl of the pooled DNA samples was arrayed on microtiter plates and subjected to gene-specific PCR.

PCR amplification using SEQ IDs NOs: 10 and 11 (Lip-A1), or SEQ IDs NOs: 12 and 13 (Lip-D1) or SEQ IDs NOs:14 and 15 (Lip-B1), or SEQ IDs NOs: 29-30 was performed in 15 μl volumes containing 20 ng pooled DNA, 0.75× ExTaq buffer (Clonetech, Mountain View, Calif.), 1.1 mM additional MgCl₂, 0.3 mM dNTPs, 0.3 μM primers, 0.009 U Ex-Taq DNA polymerase (Clonetech, Mountain View, Calif.), 0.02 units DyNAzyme II DNA Polymerase (Thermo Scientific), and if necessary 0.33M Polymer-Aide PCR Enhancer (Sigma-Aldrich®). PCR amplification was performed using an MJ Research® thermal cycler as follows: 95° C. for 2 minutes; 8 cycles of “touchdown PCR” (94° C. for 20 second, followed by annealing step starting at 70-68° C. for 30 seconds and decreasing 1° C. per cycle, then a temperature ramp of 0.5° C. per second to 72° C. followed by 72° C. for 1 minute); 25-45 cycles of 94° C. for 20 seconds, 63 or 65° C. for 30 seconds, ramp 0.5° C./sec to 72° C., 72° C. for 1-2 minutes; 72° C. for 8 minutes; 98° C. for 8 minutes; 80° C. for 20 seconds; 60 cycles of 80° C. for 7 seconds-0.3 degrees/cycle.

PCR products (2-4 μl) were digested in 96-well plates. 3 μl of a solution containing 6 mM HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid] (pH 7.0), 6 mM MgCl₂, 6 mM NaCl, 0.012× Triton® X-100, 0.03 mg/ml of bovine serum albumin, 0.5× T-Digest Buffer [Advanced Analytical Technologies, Inc (AATI), Ames, Iowa], 0.912 U each of Surveyor® Endonuclease and Enhancer (Transgenomic®, Inc.), and 0.5× dsDNA Cleavage Enzyme (AATI, Ames, Iowa) was added to the PCR product. Digestion reactions were incubated at 45° C. for 45 minutes. The specific activity of the Surveyor enzyme was 800 units/μl, where a unit was defined by the manufacturer as the amount of enzyme required to produce 1 ng of acid-soluble material from sheared, heat denatured calf thymus DNA at pH 8.5 in one minute at 37° C. Reactions were stopped by addition of 20 μl of Dilution Buffer E (AATI, Ames, Iowa) or 1×TE. The reactions were stored in the freezer until they were run on the Fragment Analyzer™ (AATI, Ames, Iowa) Capillary Electrophoresis System. Samples were run on the Fragment Analyzer™ utilizing the DNF-920-K1000T Mutation Discovery Kit (AATI, Ames, Iowa) according to the manufacturer's protocol.

After electrophoresis, the assays were analyzed using PROSize® 2.0 Software (AATI, Ames, Iowa). The gel image showed sequence-specific pattern of background bands common to all 96 lanes. Rare events, such as mutations, create new bands that stand out above the background pattern. Plants with bands indicative of mutations of interest were evaluated by TILLING individual members of a pool mixed with wild type DNA and then sequencing individual PCR products.

Example 2: Genotyping and Plant Breeding of Lip1 Lines

Plants carrying mutations confirmed by sequencing were grown as described above (e.g., the M3 plant could be backcrossed or outcrossed multiple times in order to eliminate background mutations and/or self-pollinated in order to create a plant that was homozygous for the mutation) or crossed to another plant containing Lip1 mutations in a different genome homoeolog and the process repeated. At each generation, the novel alleles were validated in the plant materials by extracting DNA, and genotyping by sequencing or by use of allele specific KASP (Kompetitive Allele Specific PCR) molecular markers (LGC Genomics, Beverly, Mass.) developed specifically for alleles of interest.

KASP genotyping was performed on DNA extracted from young leaves as described in Example 1. Each reaction consisted of 5 μl master mix (KASP High-Rox Universal 2× Master Mix, LGC Genomics) 0.14 μl KASP Assay Mix, and 40-60 ng DNA in a total reaction volume of 10.14 μl. The reaction mixture was then PCR amplified in a 96-well format using the following thermal cycling conditions: 94° C. for 15 minutes, then 10 cycles at 92° C. for 20 seconds followed by 61° C. for 60 seconds dropping 0.6° C. per cycle until reaching 55° C., then 35-40 cycles of 94° C. for 20 seconds followed by 55° C. for 60 seconds, and finally held at 8° C. until measurement. The subsequent reaction was evaluated at room temperature with a 7900 HT Fast Real-Time PCR system or QuantStudio 3system using controls of known genotypes (Applied Biosystems, Inc, Foster City, Ca, USA).

TABLE 6 Representative lines with combinations of mutation alleles in Lip-A1 and Lip-D1 Nucleotide A.A. Line Gene Mutations Mutation 1 Lip-A1 G1514A W63* Lip-D1 G1497A W62* 2 Lip-A1 G2141A W122* Lip-D1 G2125A W121* 3 Lip-A1 G2141A W122* Lip-D1 C1780T Q88* 4 Lip-A1 G1514A W63* Lip-D1 C1780T Q88*

With regard to Table 6, the genomic nucleic acid designations of the mutations in Lip1 of the A genome named Lip-A1 correspond to the position in the reference sequence SEQ ID NO: 1. Amino acid designations of the Lip1 polypeptide of the A genome named Lip-A1 correspond to the amino acid position of reference sequence SEQ ID NO: 3. One exemplary mutation in Table 5 is G1514A, resulting in a change from guanine to adenine at nucleotide position 1514 identified according to its position in the sequence of Lip-A1 SEQ ID NO: 1. This mutation results in a change from a tryptophan to a stop (*) codon at amino acid position 63 (W63*) identified according to its position in the expressed protein of Lip-A1 (SEQ ID NO: 3). Genomic nucleic acid designations of the mutations in the Lip1 gene of the D genome named Lip-D1 correspond to the position in the reference sequence SEQ ID NO: 4. Amino acid designations of the mutations in the Lip1 gene of the D genome named Lip-D1 correspond to the amino acid position of reference sequence SEQ ID NO: 6.

Example 3: Improved Shelf-Life of Lip1 Novel Alleles Analysis of Lipolytic Activity

For assessment of the impact of novel Lip1 allele combinations on shelf life of whole grain flour, seeds with moisture contents of approximately 10% were milled for 20 seconds at 22 1/s vibration frequency using a MixerMill 300 (Retsch GmbH, Haan, Germany) and 2 g samples of the resulting whole grain flour were stored in closed polyethylene bags. Accelerated aging of flour was conducted in a Percival E30BC8 (Percival Scientific Inc, Perry, Iowa, USA) with the temperature set at 37° C. for 6-8 weeks. Different incubation times and a range of additional milling, moisture content, storage media, temperatures and humidity conditions could also be employed for testing shelf life.

Analysis of triacylglycerides (TAG) and free fatty acid (FFA) contents in freshly milled and aged whole grain flour was performed to determine the content and profile of each (AOCS Method Ce 2b-11(2013); Christie W. (1993) Preparation of ester derivatives of fatty acids for chromatographic analysis. Advances in Lipid Methodology 2(69):e111). Two technical replicates on 2-5 biological replicates were analyzed for each genotypic combination. Briefly, lipids were extracted from duplicate samples of 500 mg whole grain wheat flour to which 10 mg/mL of an internal standard (TAG 15:0 Sigma-Aldrich®, St. Louis, Mo.) was added to a final concentration of 40 μg/mL. After adding 5 mL heptane, samples were placed on a platform shaker at low speed for 30 minutes, then centrifuged at 1760×g for 10 minutes at room temperature. The lipid layer was transferred and dried under a nitrogen stream (TurboVap®LV; Zymark, Hopkinton, Mass.). Lipids were resuspended in 1 mL of toluene and two 400-μL aliquots were transferred to fresh vials. A 2 mg/mL methyl ester standard (15:1 n-5 Nu-Check Prep, Inc., Elysian, Minn.) was added to a final concentration of 14.3p g/mL and also to a control vial as a derivatization blank. Alkali hydrolysis and methylation were performed by adding 1 mL of 0.5M dry methanolic sodium methoxide to a sample vial, capped, vortexed and heated at 65° C. for 1 hr. For acid catalyzed esterification and methylation, 1 mL of dry 3N methanolic HCl was added to the second sample vial, which was capped, vortexed and heated at 95° C. for 45 minutes. After vials were cooled, 1 mL of water and 1 mL of heptane each were added. The samples were vortexed and centrifuged for 2 min at 524×g. The upper, nonpolar phase of each vial was analyzed using gas chromatography (AOCS Method Ce 1-62 (1993)). Total fatty acid and TAG content were calculated relative to peak area of the internal standard (AOCS Method Ce 1-62 (1993)) and expressed as μg fatty acids (FA)/mg dry weight of sample+/−standard deviation.

TABLE 7 Conversion of TAG to FFA during accelerated aging of whole grain flour Lip1 Accelerated TAG FFA Line Genotype Aging Time (μg FA/mg) (μg FA/mg) Parent Wild-type Freshly 20.01 +/− 0.08  0.2 +/− 0.07 Express milled Parent Wild-type 6 weeks  9.80 +/− 0.05 6.71 +/− 0.13 Express 37° C. Parent Wild-type 8 weeks  6.99 +/− 0.91 7.31 +/− 1.27 Express 37° C.

The conversion of TAG to FFA due to lipase activity in whole grain flour was analyzed in the wheat variety used for the discovery of mutation alleles. “Parent Express” indicates results from the un-mutagenized parental line. The “Lip1 Genotype” of this variety is “Wild-type” indicating that this material has no induced mutation alleles. As shown in Table 7, there was a high proportion of TAG compared to FFA in freshly milled whole grain flour. After accelerated aging for 6 or 8 weeks at 37° C. (corresponding to approximately 19 or 26 weeks at room temperature), the proportion of TAG decreased and FFA levels increased. The decrease in TAG and increase in FFA over time in whole grain flour is due to lipase activity (Galliard 1986 Hydrolytic and oxidative degradation of lipids during storage of wholemeal flour: Effects of bran and germ components J. Cereal Sci. 4: 179-192).

TABLE 8 Improved shelf-life of whole grain flour from lines with novel alleles of Lip1 Accel- erated TAG FFA Percent Lip1 Aging (μg FA/ (μg FA/ Improve- Exp. Line Genotype Time mg) mg) ment 1 1 Wild-type 4 weeks  8.16 +/− 5.31 +/− 31% sibling 37° C. 0.20 0.29 1 1 Homo- 4 weeks 10.66 +/− 4.15 +/− zygous 37° C. 0.46 0.29 Mutant 2 1 Wild-type 6 weeks  9.25 +/− 5.67 +/− 17% sibling 37° C. 0.41 0.66 2 1 Homo- 6 weeks 10.87 +/− 5.10 +/− zygous 37° C. 0.15 0.12 Mutant 3 1 Wild-type 8 weeks  5.54 +/− 8.05 +/− 33% sibling 37° C. 0.82 0.49 3 1 Homo- 8 weeks  7.36 +/− 5.06 +/− zygous 37° C. 0.26 0.64 mutant 3 2 Wild-type 8 weeks  4.17 +/− 8.65 +/− 58% sibling 37° C. 0.33 0.67 3 2 Homo- 8 weeks 6.60 +/− 8.61 +/− zygous 37° C. 1.3 0.98 mutant

With regard to Tables 8 and 9, the “Experiment” column indicates materials that were analyzed in the same experiment. The “Line” column corresponds to wheat lines containing the combination of alleles in Table 6. For the Genotype column, “Wild-type sibling” indicates sibling lines resulting from the same crosses as the mutant alleles, but containing the wild-type alleles at the positions indicated in Table 6 for all the genes in the combination. “Homozygous mutant” indicates lines containing homozygous mutant alleles at the positions indicated in Table 6 for all the genes in the combination. For each experiment (Tables 8 and 9), homozygous mutants and wild-type siblings were grown under the same conditions, and grain was milled and aged at 37° C. at the same time prior to analysis.

After accelerated aging for 4 weeks at 37° C. (corresponding to approximately 12.8 weeks at room temperature), Line 1 homozygous for both Lip-A1(W63*) and Lip-D1 (W62*) had higher levels of TAG and lower levels of FFA compared to its wild-type sibling containing wild-type alleles for the Lip1 genes (Table 8, Experiment 1). The percent improvement due to the trait was calculated as the level of TAG retained in the lines with the homozygous alleles compared to their wild-type siblings. In Experiment 1, the improvement in TAG levels was 31%. FFA levels were also reduced. Improvements in TAG levels were also identified in Experiments 2 and 3 for Line 1 and in Experiment 3 for Line 2 (see Table 8).

This data demonstrates that novel alleles in Lip1 improve shelf-life of whole grain flour by reducing the degradation of TAG to FFA.

Methods: Hexanal Analysis

Oxidation of FFA by lipoxygenases produces hydroperoxides that are substrates for additional decomposition into multiple compounds including aldehydes such as hexanal. Hexanal levels produced in a sample can be used as a measure of oxidative rancidity (Fritsch and Gale, Hexanal as a measure of rancidity in low fat foods, JAOCS 54:225 (1977)). In order to test shelf-life of whole grain flour derived from grain of novel Lipase 1 mutant alleles, whole grain samples were milled and stored for 8 weeks at 37° C. and analyzed for hexanal levels as described below. Different incubation times and a range of additional milling, moisture, temperature and humidity conditions can also be employed for testing shelf life.

Whole grain flour was milled from mature seeds for 20 seconds at 22 l/s vibration frequency using a MixerMill 300 (Retsch GmbH, Haan, Germany) and stored in closed polyethylene bags. Accelerated aging of flour was conducted in a Percival E30BC8 (Percival Scientific Inc, Perry, Iowa, USA) with the temperature set at 37° C. 10 g samples of flour from 2-4 biological replicates were stored for 4-8 weeks at 37° C. Hexanal levels were analyzed by Medallion Labs (Minneapolis, Minn., USA) using a method based on gas chromatography. Units were reported in parts per million (ppm) with a lower detection limit of <0.3 ppm and an upper limit of detection of 50 ppm.

TABLE 9 Reduced hexanal formation in lines with novel alleles of Lip1 Percent Exper- Accelerated Hexanal Improve- iment Line Genotype Aging Time (ppm) ment 3 Parent Wild-type Freshly <0.3 Express milled 3 Parent Wild-type 8 weeks 0.83 +/− 0.20 Express 37° C. 3 1 Wild-type 8 weeks 1.06 +/− 0.20 9.4% sibling 37° C. 3 1 Homozygous 8 weeks 0.96 +/− 0.06 mutant 37° C. 3 2 Wild-type 8 weeks 0.90 +/− 0.14 8.9% sibling 37° C. 3 2 Homozygous 8 weeks 0.82 +/− 0.02 mutant 37° C.

As shown in Table 9, hexanal levels were below the limit of detection of <0.3 ppm in freshly milled samples. Hexanal levels increased after 8 weeks at 37° C. demonstrating the progression of oxidative rancidity. Homozygous mutant Lip1 wheat lines and Wild-type sibling controls were compared for hexanal production in whole grain flour stored at 37° C. for 8 weeks. In both wheat lines 1 and 2, hexanal production was reduced by approximately 9% in the Lip1 homozygous mutant lines compared to their sibling controls (see Table 9). This data demonstrates that novel alleles in Lip1 improve shelf-life of whole grain flour by reducing the production of hexanal.

Example 4: Improved Shelf Life by Sensory Characteristics of Lip1 Novel Alleles

Shelf life can be determined by sensory characteristics of the flour and products made from it including color, flavor, texture, aroma, appearance, performance or overall preference of the finished product. Trained panelists can be used to assess differences between materials. For example, Lip1 flour can be stored for various lengths of time, at various temperatures and/or humidities and compared to the wild-type sibling flour and/or parental flour by the panelists for preference in aroma, color, flavor, appearance and texture among other attributes. The flour can also be made into products such as bread, and the crumb and crust compared for in aroma, color, flavor, appearance or texture among other attributes. Bread or other products can also be stored for various lengths of time, at various temperatures and/or humidities and compared to the wild-type sibling flour and/or parental flour by the panelists for preference in in aroma, color, flavor, appearance or texture among other attributes.

Other methods can also be employed to assess sensory characteristics. For example, texture can be measured by a texture analyzer. Color can be measured by a Minolta chroma meter test. Compounds contributing to aroma or taste can be analyzed by liquid or gas chromatography and mass spectrometry.

Example 5: Genome Editing of Lipase 1 in Rice

Mutations in Lipase 1 can also be introduced by genome editing with the CRISPR/Cas or related system. Sequences producing guide RNAs targeting OsLip1 such as the guide sequences listed in Table 10 can be used. Guide RNA can be tested with kits such as GeneArt Precision gRNA Synthesis Kit (ThermoFisher Scientific) for complexing with GeneArt Platinum Cas9 Nuclease (ThermoFisher Scientific) in order to evaluate cleavage efficiency on template DNA prior to use.

TABLE 10 Guide sequences for targeting genome editing of OsLip1 SEQ ID Exon Guide Sequence SEQ ID NO: 31 3 ATTTAACAGCTCTTTATACA SEQ ID NO: 32 6 ATTGGATCAAGGACTTGATA SEQ ID NO: 33 6 ACCTTTGCGTTAGGCATGTT SEQ ID NO: 34 7 AGCGAGATCAAGCGCACAGA SEQ ID NO: 35 8 AAGTGGTGGTAAGTTAGATG

These guide sequences can be cloned into a vector and used for transformation of rice immature embryos using Agrobacterium tumifaciens and T-DNA (Hiei et al. (1994) Plant J. 6:271). After editing, elimination of the T-DNA can be performed by directly selecting progeny without the T-DNA or by crossing to another plant and selecting progeny without the T-DNA. Alternatively, transformation of rice and other plants can be performed using particle bombardment (Zhang et al. (1998) Mol. Breed. 4:551) with or without selectable markers followed by regeneration of plants. This process can be performed with DNA or RNA (see review by Wolter and Puchta (2017) Genome Biology 18:43).

The above examples are provided to illustrate the invention but not limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims and all their equivalents. The examples above used TILLING technology to create and identify mutations in one or more Lip1 genes of wheat and rice but one of ordinary skill in the art would understand that other methods such as targeted mutagenesis (also known as site-directed mutagenesis, site-specific mutagenesis, oligonucleotide-directed mutagenesis or genome editing) could be used to create the useful mutations disclosed herein in one or more Lip1 loci of a plant (see for example Zhang et al., PNAS 107(26):12028-12033, 2010; Saika et al., Plant Physiology 156:1269-1277, 2011). All publications, patents, and patent applications cited herein are hereby incorporated by reference.

INFORMATIONAL SEQUENCE LISTING SEQ ID NO: 1 shows a Triticum aestivum gene for Lipase 1, A genome, Lip-A1 exons 1-10 (3,280 base pairs). ATGGAGCGACGGAGGCGGGTCGCCGTGCTGGCCCTGGTGCTCCTGCTGCTCTCGGCTTGTCATGGCAGAAGAGGTATGACCTCG ATTATCTTTCTTTTTTTTTGTTGGGTAACTGTTCTAAGTTTTCCTCAAATGAATTCCAAGAACGCGTTAACTAATTCAGTAGCG ATTGGGCTGTTTACTGAATTCATTCTGACTGCCATGATTGGAGAAAGCATAGACGAATATCAGTGCACACGCAGGCATTTCAAA AGGTGTAATCATGCAGGGAGAGAAAGGGGGCAGCTATGGCACTGACGAAATTGCCCTGCTCCCTGTAAATTTCCCCAAGTTCTG ATTGCCTGTTAGCCGCACACTGGCCTACAACTGAACTAATTGAATGCACTTCTTGTTGTTGTGGCTGGGGCCTTGGGGGTTGTA TCCAAACATCTGGAGAAAGTTGTACCATCTTTGTGTGGACAGAAAAGGAAATTAGGTGGCTGGCAGTTGGAACCTACCTGGTCC CTTGTTAACAAAATGAAGTTCTGGTTGCATATGGTTGGTCACCTCCAGAAAATAAAAGGGTTGAATTAAGAAGAACGAGTTGAT GAACCGTGGCGGCAAAGAACCATTGTACTGTTGTGGAGCTTGACTTGCTCTGGGGATTCCACTAGCATCACCCATGATGCCCCC AATTGATCTTTAGCTGCCATATCTAAGCATTATGTTCAGTGATTCACAGCAAAAGACCATCATAGATTCTTTTGGAGCTTGGCT TGACAGATCTAGTGCGTGTACAACATATGGCACTTAACCTAATACTCCTATTTGATAAGGCCCCCAACTGATTTTGTCTGTCAT ATACTCATATCACTGCAATATTTTCAGTTATCCACTTGCTCTAGGTGGATTTGTGATTTGTGAATATAAGTGGTTTCAGCCTTC AGGACATGAGAATAGGTGAAATTGAATCACCTATGCCCTTTTAACTTGGCTGTCACCCGTTCATGCTTAACCTCTCCTGGTAAT TAGAACTTAGTTTGTTATATCCCTCAGATATTATATGCACAAACTTAATCAAAGTGAAATTCTGCTAAAAGCTGCCACAGATAT GACAGGCAAAAATCAATTGGGGTCATTTATTCTGTTTGCTTTCAGTTTGTTCAATTTGTTTTTCTTGGCGCAAATGTTTGTCCA TCTGCTTTGGCATCTTCTTATATCTGAAATTGATCTTCTGCACTTGTGTTCAGGATTGCATCATTTATAATATGCTAATAAACT AACTGTTTTCATTATCGCAGAGTTCTCTGTCAAGAATCACGATCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATTGT GGAGTATGCTTCGGCTGTAAGTTAAACTTATGCTCATTATTGCATTAAGTGCATGTCATGCTTTCTAAATGGAGCTTTAGTTCG TCTTTGTCTTGAGTCTTGTTAAGTCAAAATTAACTAAATACTGTCTGCAGGTGTATATGACAGATTTAACAGCTTTGTATACAT GGACATGCTCAAGATGCAATGACTTGACTCAAGTAAGAAACCTTGCAACTGTTCTCTTCCATTCATATCTATCTAGGGGTGCTT ATTTGTTTTCCTGAAACTATACTGTTCAAACAGTAAGGGATCTATCAAGATGCTCGCCAATGGTTGGTTGGGTGTCATATGCAG CTGCCCGACAACTATACAGCTTATAGAATCTGTCCTTTCTTATTTATATATTCACCTACTTCTGAAATAGGACTTCGAGATGAG GTCTCTAATTGTTGATGTGGAGAACTGCTTGCAGGTTCCTATCTTAACACACTCCATTTTAAGTTGTCATAAATTTCCGGCATA TTTCTCATCAAGTGTACTGAACTTCTCATGATATGGCCTTCCTTTTACCTGCCATTCTACGGGTGAACAATGTGACAGGCATTT GTCGGTGTAGCTCACAATCTAAATGCCATAATAGTTGCAATCAGAGGGACTCAAGAGAACAGGTACTAATCAAATTGCATGTGC TTCTAGTATTCCCAGTTAAACCGGTATGCTTTATGTGTTACTATTCTGATTTCTTGAGTCACATGTCATTTATGTTTTAGATTT GCTTGCTCAGTGTGCAGAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGCCAAATGCAAAGG TTATTGCCAATAAACTGTTTATACTTTCTTAAAAGAGAAAAGGAAAGGCAGATGCACCTTTTTGCTAAAAGACTTTCTACTACT CTGGTTAAAGGTGCACAGTGGATTTTTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGCTGTGCACAACGC AAGAAAGACATATGGGGATATCGGTGTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTGTGCACTCGATCT TGCTGTAAGTACACAAGATCCAATGTTTCACAAATACATTCAATGTCCAGACTCTTAATTCCTTCCAGGTTATATAAATTTCGG TCTTGTTTCAAATTCCTAACACCAGCACTCTAATATTTGAGGCTTGTTATTATGTAAGCTGTTGATTTTTCTCTTCAAACCCTA TCCACAGATCAAGCTCGGAAGCGACAATGTTCAACTCATGACTTTCGGACAGCCTCGTGTTGGCAATGCTGTTTTCGCCTCCTA CTTTGCCAAATATGTACCAAACACAATTCGACTGGTACACGGACATGATATTGTGCCGCATTTGCCACCTTATTTCTCCTTCCT TTCCAAACTGACGTACCACCACTTCCCAAGAGAGGTACACCTTGGGCACAAACTTATAAATATGCTTTCCAACTCCTAGGAAGC CTTTATCGCTGTGTTATGCTTAGTGCTTGCTCATATTTTAGGTATGGATCGACGAATCTGATGGCAACACAACGGAACAGATAT GTGATGCCAGCGGCGAAGACCCAAACTGCTGCAGGTTTTTACAGAGCACAGACCTCCTGCAGCTCAACTGCCTGTCTCTTTAGC TCCTAGTTCTAACATTATCCCCATCTATCGTCTTACTAGGTGCCTCTCCATATTGAGCCTGAGCATTCAGGACCATTTCACATA CCTGGGAGTAGACATGGAATCAGATGACTGGAGCACCTGCAGAATCATCACAGCACAAAGCGTTGAGCGATTACGTAAGCATCT CAGCAGCAACATCATCATGACAAAGCACGCCATCGAGGTCTCCATTGTCGAGAATAGCATGCAGACAGACTGGAGCAGTTCCAG ATAG SEQ ID NO: 2 shows the Lip-A1 coding sequence of SEQ ID NO: 1 (1,060 base pairs). ATGGAGCGACGGAGGCGGGTCGCCGTGCTGGCCCTGGTGCTCCTGCTGCTCTCGGCTTGTCATGGCAGAAGAGGAGTTCTCTGT CAAGAATCACGATCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATTGTGGAGTATGCTTCGGCTGTGTATATGACAGA TTTAACAGCTTTGTATACATGGACATGCTCAAGATGCAATGACTTGACTCAAGACTTCGAGATGAGGTCTCTAATTGTTGATGT GGAGAACTGCTTGCAGGCATTTGTCGGTGTAGCTCACAATCTAAATGCCATAATAGTTGCAATCAGAGGGACTCAAGAGAACAG TGTGCAGAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGCCAAATGCAAAGGTGCACAGTGG ATTTTTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGCTGTGCACAACGCAAGAAAGACATATGGGGATAT CGGTGTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTGTGCACTCGATCTTGCTATCAAGCTCGGAAGCGA CAATGTTCAACTCATGACTTTCGGACAGCCTCGTGTTGGCAATGCTGTTTTCGCCTCCTACTTTGCCAAATATGTACCAAACAC AATTCGACTGGTACACGGACATGATATTGTGCCGCATTTGCCACCTTATTTCTCCTTCCTTTCCAAACTGACGTACCACCACTT CCCAAGAGAGGTATGGATCGACGAATCTGATGGCAACACAACGGAACAGATATGTGATGCCAGCGGCGAAGACCCAAACTGCTG CAGGTGCCTCTCCATATTGAGCCTGAGCATTCAGGACCATTTCACATACCTGGGAGTAGACATGGAATCAGATGACTGGAGCAC CTGCAGAATCATCACAGCACAAAGCGTTGAGCGATTACGTAAGCATCTCAGCAGCAACATCATCATGACAAAGCACGCCATCGA GGTCTCCATTGTCGAGAATAGCATGCAGACAGACTGGAGCAGTTCCAGATAG SEQ ID NO: 3 shows the Lip-A1 protein sequence of SEQ ID NO. 2 (352 amino acids). MERRRRVAVLALVLLLLSACHGRREFSVKNHDQSLIYDHTLAKTIVEYASAVYMTDLTALYTWTCSRCNDLTQDFEMRSLIVDV ENCLQAFVGVAHNLNAIIVAIRGTQENSVQNWIKDLVWKQLDLSYPDMPNAKVHSGFFSSYNNTILRLAITSAVHNARKTYGDI GVIVTGHSMGGAMAAFCALDLAIKLGSDNVQLMTFGQPRVGNAVFASYFAKYVPNTIRLVHGHDIVPHLPPYFSFLSKLTYHHF PREVWIDESDGNTTEQICDASGEDPNCCRCLSILSLSIQDHFTYLGVDMESDDWSTCRIITAQSVERLRKHLSSNIIMTKHAIE VSIVENSMQTDWSSSR SEQ ID NO: 4 shows a Triticum aestivum gene for Lipase 1, D genome, Lip-D1 exons 1-10 (3,263 base pairs). ATGGAGCGACGGAGGCGGGTCGCTGTGCTGGCCCTGGTGCTCCTGCTGCTCTCGGCTTGTCATGGAAGAAGAGGTATGACCTCG ATTATCTTTCTTTTTTTTGTTGGGTAACTGTTCTAAGTTTTCCTCAAATGAATTCCAAGAACGTGTTAACTAATTCAGTAGCGA TCGGGCTGTTTACTGAGTTCATTCTGACTGCCATGATTGAAGCAAGCATAGATGAATATCAGTGCATACGCAGGCATTTCAAAA GGTGTAATCATGCAGGGAGAGAAAGGGGGCAGCTGTGGCACTGACGAAATTGCCCTGCTCCCTGTAAATTTCGCCGAGTTCTGA TTGCCTGTTAGCAGCACACTGGCCAACAACTGAACTAATTGAATGCACTTCTTGTTGTGGCTGGGGCCTTGGGGGTTGTATCCA AACATCTGGAAAAAGTTGTACTATCTTTGTGTGGACAGAAAAGGAAATTAGGTGGCCGACAGTTGGAACTTACCTGGTGCCTTG TTAACAAAATGGAGTTCTGGTTGCATATTGGTTGGTCATCTCTAGAAAATAAAAGGGTTGAATTAAGAAGAACGAGTTGATGAT GAACCGTGGCAGCAAACAACCATTGTACTGTTGTGGAGCTTGACTTGCTCTGGGGACTCTACTAGCATCATCCACGATGCCCCC AATTGATCTTTAGCTGCCATATCTAAGCATTATTTTCAGTGATTCACAGCAAAAGACCATCATAGATTCTTTTGGAGCTTGGCT TGACAGATCTAGTGCGTTTACAGCATATGGCACTTAACCTAGTACTCCTATTTGATAAGCCCCCCACCTGATTTCTGTCTGTCA TGTACTCATATCGTTGCAATATTTTCAGTTATCCACTTGCTCTAGGTGGATTCTGTGATTTGTGAATATAAGTGGTTTCAGAGA ATAGGTGAAATTGAATCATCTATGCCCTTTTAACTTGGCTGTCACCCGTTCATGCTTAACCTCTCCTGGTAATTAGAACTTACT TTTGTTCTATCCCTCAGATATTATATGCACAAACTGAATCAAAGCGAACTTGTGCTAGAAGCTGCCACAGATATGACAGGCAAA AATCAATTGGGGTCATTTATTCTGTTTGCTTTCATTTTGTTCAATTTGTCTTTCTTGGCGTAAATGTTTGTCCATCTGCTTTGG CATCTTCTTATGTCTGAAATTGATCTTCTGCACTTGTGCTCAAGATGGCATCATTTAATATGCTAGTAAACTAACTGTTTTCAT TGTCGCAGAGTTCTCTGTCAATCAGGATCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATCGTGGAATATGCTTCGGC TGTAAGTTAAACTTATGCTCATTATTCCATTAAATGCATGTCATGCTTTCTAAATGGAGCTTTAGTTCGTCTTTATCTAGAATC TTGTTAAGTCAAATTAACTAAATACTGTCTGCAGGTGTATATGACAGATTTAACAGCTTTGTATACATGGACATGCTCAAGATG CAATGACTTGACTCAAGTAAGAAACCTTCCAACTGTTCTCTTCCATTCATATCTATCTAGGGGTGCTTATTTGTTTTCCTGAAA TTACAACTGTCAAACAGTAAGGGATCTATCAAGATGCTCGCCAATGGTTGGTTGGGTGTCATATGCAGCAGCCCGTCAACTATA CAGCTTATAGAATCTGTCCTTTCTTATTTATACATTCACCTACTTCTGAAATAGGACTTCGAGATGAGGTCTCTAATTGTTGAT GTGGAGAACTGCTTGCAGGTTCCTATCTTAACACACTCCATTTTAAGTTGTCATAAATTTCCGGCATATTTCTTATCAAGTGTA CTAAACTTTTCATGATATGGCCTTCCTTTTACCTGCCATTCTACGGGTGAACAATGTGACAGGCATTTGTCGGTGTAGCTCACA ATCTAAATGCCATAATAGTTGCAATCAGAGGGACTCAAGAGAACAGGTACTAATAAAATTGCATGTGCTTCTAGTATTCCCAGT TAAACCGGTATGCTTTATGTGTTACTATTCTGATTTCTTGAGTTACATGTCATTTATGTTTTAGATTTGCTTGCTCAGTGTGCA GAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGCCAAATGCAAAGGTTATTGCCAATAAACT GTTTATACTTTCTTAAAAGAGAAAAGGAAAGGCAGATGCACGTTTTGCTAAAAGACTTTCTACTACTCTGGTTAAAGGTGCACA GTGGATTTTTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGCTGTGCACAAGGCAAGAAAGACATATGGGG ATATCGGCGTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTGTGCACTCGATCTTGCTGTAAGTACACAAG ATCCAATGTTTCACAAATACATTCAATGTCCAGACTCTTAATTCCTTCCAGGTTATAAAGTGCGGTCTTGCATCATATTCCTAA CACCAGCACTCTAATAATTGAGGCTTGTTATTATGTAAGCTGTTGATTTTTCTCTTCAAACCCTATCCACAGATCAAGCTCGGA AGCGACAATGTTCAACTCATGACTTTCGGACAGCCTCGTGTTGGCAATGCTGTTTTCGCCTCCTACTTTGCCAAATATGTGCCA AACACAATTCGACTGGTACACGGACATGATATCGTGCCGCATTTGCCACCTTATTTCTCCTTTCTTTCCAAACTGACGTACCAC CACTTCCCAAGAGAGGTATACCTTGGGCACAAACGTATAATTACGCTTTCTTGGATATCAACTCAGTCCCTGGGCTTCATCTCT GTGCTATGCTTATTCCGCCCAAATTTCAGGTATGGATCGATGATTCTGACGACAACACAACCGAACAGATTTGTGATGCCAGCG GCGAAGACCCAAACTGCTGCAGGTTTTACAGCTCAGACCTTCCTTGCAGTTCAATTGCCTGTCTCTTCTCCTAATTCTAACATT TCCCCACTGATCATTTTACTAGGTGCCTCTCCATACTGAGTTTGAGCATTCAGGACCATTTCACATACCTGGGAGTCGATATGG AATCAGATGACTGGAGCACCTGCAGAATCATCACAGCACAAAGTGTTGAGCGACTACGGAAGGATCTCGCCAGCAACATCATCA TGACAAAGCACGGCGTCGAGGTCTCCATTGTCGAGAATAGCGTGCAGACAGACTGGAGCAGTTCCATATAG SEQ ID NO: 5 shows the Lip-D1 coding sequence of SEQ ID NO. 4 (1,056 base pairs). ATGGAGCGACGGAGGCGGGTCGCTGTGCTGGCCCTGGTGCTCCTGCTGCTCTCGGCTTGTCATGGAAGAAGAGAGTTCTCTGTC AATCAGGATCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATCGTGGAATATGCTTCGGCTGTGTATATGACAGATTTA ACAGCTTTGTATACATGGACATGCTCAAGATGCAATGACTTGACTCAAGACTTCGAGATGAGGTCTCTAATTGTTGATGTGGAG AACTGCTTGCAGGCATTTGTCGGTGTAGCTCACAATCTAAATGCCATAATAGTTGCAATCAGAGGGACTCAAGAGAACAGTGTG CAGAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGCCAAATGCAAAGGTGCACAGTGGATTT TTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGCTGTGCACAAGGCAAGAAAGACATATGGGGATATCGGC GTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTGTGCACTCGATCTTGCTATCAAGCTCGGAAGCGACAAT GTTCAACTCATGACTTTCGGACAGCCTCGTGTTGGCAATGCTGTTTTCGCCTCCTACTTTGCCAAATATGTGCCAAACACAATT CGACTGGTACACGGACATGATATCGTGCCGCATTTGCCACCTTATTTCTCCTTTCTTTCCAAACTGACGTACCACCACTTCCCA AGAGAGGTATGGATCGATGATTCTGACGACAACACAACCGAACAGATTTGTGATGCCAGCGGCGAAGACCCAAACTGCTGCAGG TGCCTCTCCATACTGAGTTTGAGCATTCAGGACCATTTCACATACCTGGGAGTCGATATGGAATCAGATGACTGGAGCACCTGC AGAATCATCACAGCACAAAGTGTTGAGCGACTACGGAAGGATCTCGCCAGCAACATCATCATGACAAAGCACGGCGTCGAGGTC TCCATTGTCGAGAATAGCGTGCAGACAGACTGGAGCAGTTCCATATAG SEQ ID NO: 6 shows the Lip-A1 protein sequence of SEQ ID NO. 5 (351 amino acids). MERRRRVAVLALVLLLLSACHGRREFSVNQDQSLIYDHTLAKTIVEYASAVYMTDLTALYTWTCSRCNDLTQDFEMRSLIVDVE NCLQAFVGVAHNLNAIIVAIRGTQENSVQNWIKDLVWKQLDLSYPDMPNAKVHSGFFSSYNNTILRLAITSAVHKARKTYGDIG VIVTGHSMGGAMAAFCALDLAIKLGSDNVQLMTFGQPRVGNAVFASYFAKYVPNTIRLVHGHDIVPHLPPYFSFLSKLTYHHFP REVWIDDSDDNTTEQICDASGEDPNCCRCLSILSLSIQDHFTYLGVDMESDDWSTCRIITAQSVERLRKDLASNIIMTKHGVEV SIVENSVQTDWSSSI SEQ ID NO: 7 shows a Triticum aestivum gene for Lipase 1, B genome (3,460 base pairs). ATGGGGAGGTGGAGGCGGGCCGGCGTGCTGGCTCTGGTGCTCCTGCTGCTCTCCGCTTGCCATGGAAGACGAGgtatggtcttg gttaccttttctttcctttttctttgcgaaacatagtaagtagaacatatcacaaacgtgcttcggttaccaattttgatgctt gcttgttgggtgactgttctaagttttcctcaaatgaatttccaagaacgtgttagctaattcagtagcgatcgggctgtttac tgaattcattctgactgccataattagagaaagcataagatgaatgtcagtgcatacgcaggcttttcaaaaggtgtaatcatg cagggagaggaagggggcagctgtggcagactgacgaaattgccctgctccctgtaaatttcgccaagttctgattgcctgtta gccgcgcactggccaacaactcaactaattgaatgcgcttcttgttgttgtggctggggccttgggggttgtatccaaacatct ggaaaaagttgtactatctttgtgtggacagaaaaggaaattaggtggctgacagttggaacatacctggtgccttgttaacat aacgaagttctggttgcatatggttggtcacctccagaaaatagaagtgttgaattaagaagaacgagtcgatgaaccgtggca ggcaaacagccattatactgttgtggagcttgacttgctctggggattctactagcatcatccatgatgcccccaattgatctt tagctgccatatctaagcattattttcagtgattcacagcaaaagaccatcataacttcttttggagcttggcttgacagatct agtgcgtttacaacatatggcacttaacctaatactcctatttgataaggcccccaactgatttctgtctgtcatatactcata tcattgcaatattttcagttatccacttgctctaggtggattctgtgatttgtgaatataagtggttttcagccttcaggacat gagaataggtgaaattgaatcatctatgcccttttaacttggctgtcacccgttcatgcttaacctctcctggtaattagaact tacttttgttctatacacaaacttaatcaaagtgaacttgtgctaaaagctgccacagatatgacaggcaaaaatcaattgggg tcatttattctgtttgctttcagtttgttcaatttgtttttcttggcataaatgtttgtccatctgctttggcatcttcttata tctgaaattgatcttctgcacttgtgttattgcatcatttaatatgctaataaactaactgttttcattatcgcagAGTTCTCT GTCAAGAATCACGGTCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATCGTGGAGTATGCTTCGGCTgtaagtttaact tatgctcattattgcattaaatgcatgtcatgctttctaaatagagctttagtttgtctttgtcttgaatcttgttaagtcaaa ttaactaaatactgtctgcagGTGTATATGACAGATTTAACAGCTTTGTATACATGGACATGCTCAAGATGCAATGACTTGACT AAgtaagaaaccgtccaactgttctcttccattcatatctactccctccgtcccaaaattattgtcttaaatttgtctagatac ggatgtacctaatactaaaacgtgacttgatacatccgtatttagacaaatctaagacaagaattttgggacggagggagtatc taggggtgcttatttgttttcctgaaattataactgttcaaacagtaagggatctatcaagatgctcgccaatggttggttagg tgtcatatgcagcagcccgtcaactatacagcttatagaatctgtcatttcttatttatacattcacctacttctgaaatagGA CTTCGAGATGAGGTCTCTAATTGTTGATGTGGAGAACTGCTTGCAGgttcctatcttaacacactccattttaagttgtcataa atttccggcatatttcttatcaagtgtactgaacatctcatgatatggccttccttttacctgccattctacgggtgaacaatg tgacagGCATTTGTCGGTGTAGCTCACAATCTAAATTCCATAATAGTTGCAATCAGAGGAACTCAAGAGAACAGgtactaatca aattgcatgtgcttctagtattcccagttaaaccggtatgctttatgtgttactattccgatttcttgagtcacatgtcattta tgttttagatttgcttgctcagTGTGCAGAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGC CAAATGCAAAGgttattgccaataaactgtttatactttcttaaaagagaaaaggaaaggcagatgcacctttttgctaaaaga ctttctactactctggttaaagGTGCACAGTGGATTTTTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGA TGTGCACAACGCAAGAAAGACATATGGGGATATTGGTGTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTG TGCACTCGATCTTGCTgtaagtacacaagatccaatgtttcacaaatacattcaatgtccagactcttaattcctcccaggtta taaattgcggtcttgtatcaaattcctaacaccagcactctaatatttgaggcttgttattatgtaagctgttgatttttctct tcaaaccctatccacagATCAAGCTCGGAAGCGACAATGTTCAACTCATGACTTTCGGACAGCCTCGTGTCGGCAATGCTGTTT TCGCCTCCTACTTTGCCAAATATGTACCAAACACAATTCGACTGGTACACGGACATGATATTGTGCCGCATTTGCCACCTTATT TCTCCTTTCTTTCCAAACTGACGTACCACCACTTCCCAAGAGAGgtataccttgggcacaaacttataaatatgctttccaact cctaggaagcctttatcgctgtgttatgcttagtgcttgctcatattttagGTATGGATCAACGAATCTGATGGCAACACAACG GAACAGATATGTGATGCCAGCGGCGAAGACCCAAACTGCTGCAGgtttttacagagcacagaccttccttgcggctcaactgct tgtctctttagctcctagttctgacattatccccatcgatcgttttactagGTGCCTCTCCATATTGAGCCTGAGCATTCAGGA CCATTTCACATACCTGGGAGTAGACATGGAATCAGATGACTGGAGCACCTGCAGAATCATCACAGCACAAAGCGTTGAGCGATT ACGTAAGGATCTCGGCAGCAACATCATCATGACAAAGCACGGCGTCGAGGTCTCCATTGTCGAGAATAGCATGCAGACAGACTG GAGCAGTTCCAGATAG SEQ ID NO: 8 shows the Lip-B1 coding sequence of SEQ ID NO. 4 (1,059 base pairs). ATGGGGAGGTGGAGGCGGGCCGGCGTGCTGGCTCTGGTGCTCCTGCTGCTCTCCGCTTGCCATGGAAGACGAGAGTTCTCTGTC AAGAATCACGGTCAGAGTCTTATATATGATCATACTCTTGCTAAGACCATCGTGGAGTATGCTTCGGCTGTGTATATGACAGAT TTAACAGCTTTGTATACATGGACATGCTCAAGATGCAATGACTTGACTCAAGACTTCGAGATGAGGTCTCTAATTGTTGATGTG GAGAACTGCTTGCAGGCATTTGTCGGTGTAGCTCACAATCTAAATTCCATAATAGTTGCAATCAGAGGAACTCAAGAGAACAGT GTGCAGAATTGGATCAAGGACTTGGTATGGAAGCAGCTTGATCTAAGCTATCCAGACATGCCAAATGCAAAGGTGCACAGTGGA TTTTTCTCCTCCTATAATAATACAATTTTGCGTCTAGCTATCACAAGTGATGTGCACAACGCAAGAAAGACATATGGGGATATT GGTGTCATAGTCACAGGGCACTCAATGGGAGGAGCCATGGCTGCCTTCTGTGCACTCGATCTTGCTATCAAGCTCGGAAGCGAC AATGTTCAACTCATGACTTTCGGACAGCCTCGTGTCGGCAATGCTGTTTTCGCCTCCTACTTTGCCAAATATGTACCAAACACA ATTCGACTGGTACACGGACATGATATTGTGCCGCATTTGCCACCTTATTTCTCCTTTCTTTCCAAACTGACGTACCACCACTTC CCAAGAGAGGTATGGATCAACGAATCTGATGGCAACACAACGGAACAGATATGTGATGCCAGCGGCGAAGACCCAAACTGCTGC AGGTGCCTCTCCATATTGAGCCTGAGCATTCAGGACCATTTCACATACCTGGGAGTAGACATGGAATCAGATGACTGGAGCACC TGCAGAATCATCACAGCACAAAGCGTTGAGCGATTACGTAAGGATCTCGGCAGCAACATCATCATGACAAAGCACGGCGTCGAG GTCTCCATTGTCGAGAATAGCATGCAGACAGACTGGAGCAGTTCCAGATAG SEQ ID NO: 9 shows the Lip-B1 protein sequence of SEQ ID NO. 5 (353 amino acids). MGRWRRAGVLALVLLLLSACHGRREFSVKNHGQSLIYDHTLAKTIVEYASAVYMTDLTALYTWTCSRCNDLTQDFEMRSLIVDV ENCLQAFVGVAHNLNSIIVAIRGTQENSVQNWIKDLVWKQLDLSYPDMPNAKVHSGFFSSYNNTILRLAITSDVHNARKTYGDI GVIVTGHSMGGAMAAFCALDLAIKLGSDNVQLMTFGQPRVGNAVFASYFAKYVPNTIRLVHGHDIVPHLPPYFSFLSKLTYHHF PREVWINESDGNTTEQICDASGEDPNCCRCLSILSLSIQDHFTYLGVDMESDDWSTCRIITAQSVERLRKDLGSNIIMTKHGVE VSIVENSMQTDWSSSR SEQ ID NO: 10  Ta_Lip1_A_L2       GAAATTGATCTTCTGCACTTGTGTTCAGGA SEQ ID NO: 11  Ta_Lip1_A_R1       TGGGGATAATGTTAGAACTAGGAGCTA SEQ ID NO: 12  Ta_Lip1_DB_L1      GACAGGCAAAAATCAATTGGGGTCATTT SEQ ID NO: 13  Ta_Lip1_D_R3       TGATCAGTGGGGAAATGTTAGAATTAGGAGA SEQ ID NO: 14  Ta_Lip1_B_L1       CTGAAATTGATCTTCTGCACTTGTGTTATTGCA SEQ ID NO: 15  Ta_Lip1_B_R1       AGCATAACACAGCGATAAAGGCTTCCTAGG SEQ ID NO: 16  Ta_Lip1_B_Lmarker  TCTCTGTCAAGAATCACGGTC SEQ ID NO: 17  Ta_Lip1_B_Rmarker  GCTGCTGCATATGACACCTA SEQ ID NO: 18  Ta_Lip1_L1         CACAGTGGATTTTTCTCCTCCT SEQ ID NO: 19  Ta_Lip1_R1         CCGATATCCCCATATGTCTTTC SEQ ID NO: 20  Ta_Lip2_L1         GACCCAGTTTCAACAGCAAC SEQ ID NO: 21  Ta_Lip2_R1         CGGACCTAACAGCTCTATATA SEQ ID NO: 22  Ta_Lip3_L3         CACTTGATCTTGTTGTGAACTAC SEQ ID NO: 23  Ta_Lip3_R3         GCGTGAGGCAAGTATCTCTT SEQ ID NO: 24  Ta_GAPD_F          TGTCCATGCCATGACTGCAA SEQ ID NO: 25  Ta_GAPD_R          CCAGTGCTGCTTGGAATGATG SEQ ID NO: 26 shows an Orzya sativa gene for Lipase 1, OsLip1 exons 1-10 (3672 base pairs). ATGATGGGAGGTTGGTTTGGATGTGTCTGTAGGTTCATGGAGAGGTGGAGATGCGTCAGTGTGTTGGCTCTGGTGCTCTTGCTG TCAAATGCTTCCCATGGGAGAGGTAGTTTCATGTGACCCTTTGCCCTAAGTTTCCAATTTTGATGCTTGTTGGGTAATTGTTCT AAGTTTGCCTCAATGTATTCCAAAATGGGTTAACGTTTAACAGAACAAATAGCAAATCAAGGTATTAGTAACTGACTGCTTTGG TGGGAGAAAGCAGACCAATGCTTATGCAGGCATCTGTAATAAGGTTTAATTTTCTAGAGAAATGGGGAGTGCTGATGATGGATG AGATTGTCTTGTTCTTTTGATTTTACCAAGTTCTGGGTTTTGGCTGTCGGTTTGGTATGAAATGACCAGTAATTTACTGGAGTT ACTGGACTAGTTGACCAAGTTATAGCTGTTCTGCTGTTGTAATTGGGGATGCATGAGCAAGAGTAGGTGGGTGACAGTTGGAAT TTCTTGCTGCCCTGTCCTTACTAATATAATTGATGCCCTAATTGCTGAAAAGGAAGACAAGGTTGGTGGGTGAGTAGAAAATAA CAACATTGGAAATAAAGAAGTTGATGGCAAGAAAGATAATGGATATAATTGTGCTCAGAGATTCCTATTATTCCAAACACATAT TTGAACCTTAAACCTAATATTTATTGAGTTCTCAACTTCTTTCTTGCTTCCTTAAACTTGAATTCCACTTCATTACAGCTTGTG GATTCTTTGCATTCATAAAACTTTGTCTCAGGATCCTGAAATATGTGAAGTTCAAACATTTATAGAGTATTCTTTAGTTTGGCC TTCACCAATGCAAGCTTGACACTCTGTTGGTGAAAGTTTATTTAGTACTGCTATATGCTGCATGCCATCTGCCATATATTATAT ACACAACTTGATCGAGCATTTTTTCTGCACCACCTACTCCGATTGGGCTTAATTTCACAAGAAGATTTAGCTAGCAGTTAGCAC AATTTTTGGGGCATTAATAGTTACTCGTCACATGGAACTGCTGATTTGAGGTTTAAGATTGAGCTTGAAGCTACCACAAGTTTA CCAGGCCAGAACGTGATACTGGGGCCACTTTTCCTATAAGTTTGATGCCATAAAAATTGAGAATATGAAATCAGCTTTCGGCTT TCCTTCACTTATGAGCAAATGGGGCTTAATATCTTAAGCATGTCCAAACAAGTCAAATGTCCTTAATCAATTTTCTTTTCATTT GTCAACATTTGATTTTATTACCGAATATAATGTCGGTTCGTCTGCTGCATACCTTCGTATAGTAGATGTAGTTGATCATCAATG TTTGTATTCATGCTCTCATCATCAAAAACTGGAGTGAACTAACTTTTTTCATTATAACAGATATCTCTGTCCAGCACTCTCAGC AAACTTTGAACTATAGCCATACTCTTGCCATGACTCTTGTGGAATATGCTTCTGCTGTAAGAAACTTTTCCTTATTTTTACATA AGCAGTATGTGTTCTAGGTAACATTTCTGTTCATGTTTTGCATTTCACAAAGGCAACTGTCTCTCTTTCTTGTTTTCTCCTTTT GCCCCAAAATAAAATCAGCTACTTTAAAAATGAAAAAAGAAGAAGAAGAACTTAGCTGATGGCTCTTCGTTTTCTCCAGGTGTA CATGACAGATTTAACAGCTCTTTATACATGGACGTGCTCAAGGTGTAATGACTTGACTCAAGTAAGAAGCCTTCAAGTTTGTTC TGTTCAATTCATATTTAGAGGGATACTCATTAACTGCGAAGTAAAGCTTATATTGTTACTGATGGTTGGGGGCAGAATCACCTC AAATGTCCGCTTGTCAGGATCTGCCATTCCTCTTAATGAATCATAAAAGCATTTTCCTTTTCTTCTTCTTTAGGAAAAATATTT CTTTTGTCATGGACAGGATAAATTTGTTGCTAGTTTTGATATGACTACATTTGAAATAGGGCTTTGAGATGAAATCTCTAATCG TGGATGTGGAGAACTGCCTACAGGTTCTTATCTTACAAATTTCAAACTAATATCATAAATTCTCGATGATATTTGAGTACATTA AGCGTTTAATGATTTTATTTATATTGTGTGACACTATGTGGGTGAACAATGTAACAGGCATTCGTTGGTGTGGATTATAATTTA AATTCAATAATTGTTGCAATAAGAGGGACTCAAGAAAACAGGTACACTGATTTTGCACAGTGTGTTACTGTTCCCTGTTCCCAT GTGATTTATATCTTGATTTGCTTACTCAGTATGCAGAATTGGATCAAGGACTTGATATGGAAACAACTTGATCTGAGCTATCCT AACATGCCTAACGCAAAGGTTATTATCGCTAGCAAAGTGTTTCTATCTCCTTAAGTCCTTTTATTAAAAGAAGATCAGTGCCTT TTTTTTCCCCTAAAATATCTCCACTTCTCTGTTTAAAGGTGCACAGTGGATTTTTCTCCTCCTATAATAACACGATTTTACGTC TAGCTATCACAAGTGCTGTCCACAAGGCAAGACAGTCATATGGAGATATCAATGTCATAGTTACAGGGCACTCAATGGGAGGAG CCATGGCATCCTTCTGTGCGCTTGATCTCGCTGTAAGTACCCCCGAGGCTCAAAGTTTTACTAATACATCCAGTGTTCAGATTA CAGACTCTTCTAAGACATTATAGATGTAATATCTGTATCACATTCTTTCCATAAAAAAATTGAATGCCATCATTGGTTGTTATG TAAACTGATACAGTCTTGTTCTTTTACTCTGTCCACAGATCAATCTTGGAAGCAATAGTGTTCAACTCATGACTTTCGGACAGC CTCGTGTTGGCAATGCTGCTTTTGCCTCTTATTTTGCCAAATATGTGCCCAACACGATTCGAGTCACACATGGACATGATATTG TGCCACATTTGCCCCCTTATTTCTCCTTTCTTCCCCATCTAACTTACCACCACTTCCCAAGAGAGGTATGCCTCACAGGCTTGC ACATAAGCTAATTAAGAATGCGCTCTTGTACACTTAACTTGGCCCTGGCTTTATCTATTTTATCACTATAGCACACTTTATGAA TTTTTGTATTAACACCCTTTTTATATTTACCATTAATAATACAAAATCAATGCCTAGTGCAGCAAGTTGTTAGATGCTCTGCAC ACCTTCCATGGGACAATGATACTAATCTAAATCAAATATGCTAATATTCTTTAGAGATGTGGTGTTACATCCTGTACAGTGTAC ACACATAATATGCTTGTTCGAATTTCAGGTATGGGTCAATGATTCTGAGGGCGACATAACCGAACAGATATGTGATGATAGTGG TGAAGATCCAAATTGCTGCAGGTTTAGAGGCTCATTTTAACAACCTAACAACTCAAATCTGGTTTTTTTAGCTTCTAATTATAA TTTCTGTTCCCTCGTTTATTTCCTAGGTGCATCTCCACATGGAGTTTGAGCGTTCAAGACCATTTCACATACCTGGGAGTTGAT ATGGAAGCTGACGACTGGAGCACTTGTAGAATCATCACAGCTGAAAATGTTAGGCAACTCCAAAAGGATCTCGCCAGCAACATC ATCGTCTCCAAGCACTCTGTCGATGTCACTATTGTAGAACCTAGTTCACAAACATATTGA SEQ ID NO: 27 shows the OsLip1 coding sequence of SEQ ID NO: 26 (1,077 base pairs). ATGATGGGAGGTTGGTTTGGATGTGTCTGTAGGTTCATGGAGAGGTGGAGATGCGTCAGTGTGTTGGCTCTGGTGCTCTTGCTG TCAAATGCTTCCCATGGGAGAGATATCTCTGTCCAGCACTCTCAGCAAACTTTGAACTATAGCCATACTCTTGCCATGACTCTT GTGGAATATGCTTCTGCTGTGTACATGACAGATTTAACAGCTCTTTATACATGGACGTGCTCAAGGTGTAATGACTTGACTCAA GGCTTTGAGATGAAATCTCTAATCGTGGATGTGGAGAACTGCCTACAGGCATTCGTTGGTGTGGATTATAATTTAAATTCAATA ATTGTTGCAATAAGAGGAACTCAAGAAAACAGTATGCAGAATTGGATCAAGGACTTGATATGGAAACAACTTGATCTGAGCTAT CCTAACATGCCTAACGCAAAGGTGCACAGTGGATTTTTCTCCTCCTATAATAACACGATTTTACGTCTAGCTATCACAAGTGCT GTCCACAAGGCAAGACAGTCATATGGAGATATCAATGTCATAGTTACAGGGCACTCAATGGGAGGAGCCATGGCATCCTTCTGT GCGCTTGATCTCGCTATCAATCTTGGAAGCAATAGTGTTCAACTCATGACTTTCGGACAGCCTCGTGTTGGCAATGCTGCTTTT GCCTCTTATTTTGCCAAATATGTGCCCAACACGATTCGAGTCACACATGGACATGATATTGTGCCACATTTGCCCCCTTATTTC TCCTTTCTTCCCCATCTAACTTACCACCACTTCCCAAGAGAGGTATGGGTCAATGATTCTGAGGGCGACATAACCGAACAGATA TGTGATGATAGTGGTGAAGATCCAAATTGCTGCAGGTGCATCTCCACATGGAGTTTGAGCGTTCAAGACCATTTCACATACCTG GGAGTTGATATGGAAGCTGACGACTGGAGCACTTGTAGAATCATCACAGCTGAAAATGTTAGGCAACTCCAAAAGGATCTCGCC AGCAACATCATCGTCTCCAAGCACTCTGTCGATGTCACTATTGTAGAACCTAGTTCACAAACATATTGA SEQ ID NO: 28 shows the OsLip1 protein sequence of SEQ ID NO: 26 (358 amino acids). MMGGWFGCVCRFMERWRCVSVLALVLLLSNASHGRDISVQHSQQTLNYSHTLAMTLVEYASAVYMTDLTALYTWTCSRCNDLTQ GFEMKSLIVDVENCLQAFVGVDYNLNSIIVAIRGTQENSMQNWIKDLIWKQLDLSYPNMPNAKVHSGFFSSYNNTILRLAITSA VHKARQSYGDINVIVTGHSMGGAMASFCALDLAINLGSNSVQLMTFGQPRVGNAAFASYFAKYVPNTIRVTHGHDIVPHLPPYF SFLPHLTYHHFPREVWVNDSEGDITEQICDDSGEDPNCCRCISTWSLSVQDHFTYLGVDMEADDWSTCRIITAENVRQLQKDLA SNIIVSKHSVDVTIVEPSSQTY SEQ ID NO: 29  OsLip1_L2  CACCTACTCCGATTGGGCTTAATTTCACA SEQ ID NO: 30  OsLip1_R8  GAACAAGACTGTATCAGTTTACATAACAACCAATG SEQ ID         Exon  Guide Sequence SEQ ID NO: 31  3     ATTTAACAGCTCTTTATACA SEQ ID NO: 32  6     ATTGGATCAAGGACTTGATA SEQ ID NO: 33  6     ACCTTTGCGTTAGGCATGTT SEQ ID NO: 34  7     AGCGAGATCAAGCGCACAGA SEQ ID NO: 35  8     AAGTGGTGGTAAGTTAGATG 

What may be claimed is:
 1. Wheat flour from wheat grain comprising one or more human induced mutations in a Lipase 1 (Lip1) gene in at least A and D genomes, wherein the one or more human induced mutations in the Lip1 gene reduce Lipase 1 activity as compared to Lipase 1 activity from a wild type Lip1 gene, and wherein the flour comprises a characteristic selected from the group consisting of: (a) increased hydrolytic stability as measured by reduction in the rate of conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant; (b) increased oxidative stability as measured by a reduction in degradation by available oxygen as compared to flour from grain of a wild type wheat plant; (c) at least a 10% reduction in conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant; (d) at least a 5% reduction in hexanal production as compared to flour from grain of a wild type wheat plant; and (e) combinations thereof.
 2. The wheat flour of claim 1, wherein the flour has at least a 10% reduction in the conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant.
 3. The wheat flour of claim 1, wherein the flour has increased hydrolytic stability as measured by reduction in the rate of conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant.
 4. The wheat flour of claim 1, wherein the flour from the wheat grain has increased oxidative stability as measured by a reduction in degradation by available oxygen as compared to flour from grain of a wild type wheat plant.
 5. The wheat flour of claim 1, wherein the flour has at least a 5% reduction in hexanal production as compared to flour from grain of a wild type wheat plant.
 6. The wheat flour of claim 1, wherein the wheat grain further comprises one or more human induced mutations in the Lip1 gene of a B genome.
 7. The wheat flour of claim 1, wherein the flour is selected from the group consisting of: a whole grain flour, an ultrafine milled whole grain flour, a coarse fraction, a bran, and mixtures thereof.
 8. The wheat flour of claim 1, wherein the wheat grain comprises an amino acid change recited in Table
 1. 9. The wheat flour of claim 1, wherein the wheat grain comprises an amino acid change recited in Table
 2. 10. The wheat flour of claim 6, wherein the wheat grain comprises an amino acid change recited in Table
 3. 11. Wheat flour from wheat grain comprising one or more human induced mutations in a Lipase 1 (Lip1) gene in at least A and B genomes, wherein the one or more human induced mutations reduce Lipase 1 activity as compared to Lipase 1 activity from a wild type Lip1 gene, and wherein the flour comprises a characteristic selected from the group consisting of: (a) increased hydrolytic stability as measured by reduction in the rate of conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant; (b) increased oxidative stability as measured by a reduction in degradation by available oxygen as compared to flour from grain of a wild type wheat plant; (c) at least a 10% reduction in conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant; (d) at least a 5% reduction in hexanal production as compared to flour from grain of a wild type wheat plant; and (e) combinations thereof.
 12. The wheat flour of claim 11, wherein the flour has at least a 10% reduction in the conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant.
 13. The wheat flour of claim 11, wherein the flour has increased hydrolytic stability as measured by reduction in the rate of conversion of mono-, di- or tri-acylglycerides (TAG) to free fatty acids (FFA) as compared to flour from grain of a wild type wheat plant.
 14. The wheat flour of claim 11, wherein the flour has increased oxidative stability as measured by a reduction in degradation by available oxygen as compared to flour from grain of a wild type wheat plant.
 15. The wheat flour of claim 11, wherein the flour has at least a 5% reduction in hexanal production as compared to flour from grain of a wild type wheat plant.
 16. The wheat flour of claim 11, wherein the flour is selected from the group consisting of: a whole grain flour, an ultrafine milled whole grain flour, a coarse fraction, a bran, and mixtures thereof.
 17. The wheat flour of claim 11, wherein the wheat grain further comprises one or more mutations in the Lip1 gene of a D genome.
 18. The wheat flour of claim 11, wherein the wheat grain comprises an amino acid change recited in Table
 1. 19. The wheat flour of claim 11, wherein the wheat grain comprises an amino acid change recited in Table
 3. 20. The wheat flour of claim 17, wherein the wheat grain comprises an amino acid change recited in Table
 2. 